- Email: [email protected]
Schedule of Oral Presentations
SCHEDULE OF ORAL PRESENTATIONS Thursday, February 8, 2007 8:00AM to 10:00AM
Oral Plenary Session I
Continental Ballroom 1-9
8:00
1
A RANDOMIZED CONTROLLED TRIAL OF 17-HYDROXYPROGESTERONE CAPROATE (17-OHPC) FOR THE PREVENTION OF PRETERM BIRTH IN TWINS
STEVE CARITIS1, DWIGHT ROUSE1, 1NICHD MFMU Network, Bethesda, Maryland
8:15
2
LONG TERM FOLLOW-UP OF INFANTS RECEIVING SINGLE VS REPEAT COURSES OF ANTENATAL CORTICOSTEROIDS (ACS) FROM THE MFMU RCT
RONALD WAPNER1, 1NICHD MFMU Network, Bethesda, Maryland
8:30
3
PERI-OPERATIVE PROGNOSTIC FACTORS IN TWIN-TO-TWIN TRANSFUSION SYNDROME TREATED BY FETOSCOPIC LASER OCCLUSION OF CHORIONIC PLATE ANASTOMOSES
JULIEN STIRNEMANN1, SYLVIE CHEVRET2, LAURENCE BUSSIERES3, YVES VILLE4, 1CHI Poissy Saint Germain, Paris, France2Universite´ Paris 7, INSERM 444, Statistics, Paris, France3De´le´gation Re´gionale a` la Recherche Clinique, Hopital Saint-Louis, Clinical Research, Paris, France4Universite´ Paris Ouest UVSQ, CHI Poissy Saint Germain en Laye, Paris, France
8:45
4
COMPREHENSIVE PROTEOMIC ANALYSIS OF HUMAN CERVICAL-VAGINAL FLUID AND IDENTIFICATION OF NOVEL BIOMARKERS FOR PREDICTION OF SPONTANEOUS PRETERM BIRTH
LEONARDO PEREIRA1, JODI LAPIDUS2, XINFANG LU3, MICHAEL GRAVETT4, SRINIVASA NAGALLA3, 1Oregon Health & Science University, Obstetrics and Gynecology, Portland, Oregon 2Oregon Health & Science University, Public Health & Preventive Medicine, Portland, Oregon 3Oregon Health & Science University, Pediatrics, Portland, Oregon 4University of Washington, Obstetrics and Gynecology, Seattle, Washington
9:00
5
LONG-TERM NEURODEVELOPMENTAL OUTCOME IN TWIN-TO-TWIN TRANSFUSION SYNDROME IN THE EUROFOETUS TRIAL
LISA O¨RTQVIST1, SYLVIE CHEVRET2, LAURENCE BUSSIERES3, STEPHANIE STARACI1, FABIENNE HUARD1, YVES VILLE1, 1ParisOuest University VSQ, Department of Gynecology and Obstetrics, Paris, France2Universite´ Paris 7, INSERM 444, Statistics, Paris, France3De´le´gation Re´gionale a` la Re´cherche Clinique, Hopital Saint-Louis, Clinical Research, Paris, France
9:15
6
THE EFFECT OF SFLT-1 OVER-EXPRESSION IN PREGNANT MICE ON BLOOD PRESSURE OF THE OFFSPRING LATER IN LIFE
FANGXIAN LU1, EGLE BYTAUTIENE1, ESTHER TAMAYO1, PHYLLIS GAMBLE1, GARLAND D ANDERSON1, GARY DV HANKINS1, MONICA LONGO1, GEORGE SAADE1, 1University of Texas Medical Branch, Obstetrics & Gynecology/Maternal Fetal Medicine, Galveston, Texas
9:30
7
LOW BIRTH WEIGHT AMONG ADULTS WITH A FAMILY HISTORY OF DIABETES DECREASES THE RISK OF METABOLIC SYNDROME.
BETTINA PAEK1, KATHERINE EASTWOOD1, KRISTINA UTZSCHNEIDER2, JENNY TONG2, FERNANDO GERCHMAN2, DREW ROBILIO1, WILFRED FUJIMOTO2, STEVEN KAHN2, DARCY CARR1, 1University of Washington, Obstetrics and Gynecology, Seattle, Washington 2University of Washington, Medicine, Seattle, Washington
9:45
8
FETAL ORIGINS OF DISEASE: ESSENTIAL NUTRIENT SUPPLEMENTATION PREVENTS ADULT METABOLIC DISEASE IN A TRANSGENERATIONAL MODEL OF IUGR
KJERSTI AAGAARD-TILLERY1, WILLIAM HOLLAND2, ROBERT MCKNIGHT3, SHANNON JENKINS3, XING YU3, SCOTT SUMMERS2, WARE BRANCH4, ROBERT LANE3, 1University of Utah, Obstetrics and Gynecology, Salt Lake City, Utah 2University of Utah, Biochemistry and Molecular Biology, Salt Lake City, Utah 3University of Utah, Division of Neonatology, Salt Lake City, Utah 4University of Utah, Obstetrics and Gynecology, SLC, Utah
December 2006 XLIII
Thursday, February 8, 2007 1:15PM to 3:30PM
Oral Concurrent Session 1
Continental Ballroom 4
1:15
9
17 ALPHA HYDROXY-PROGESTERONE CAPROATE (17P) TREATMENT REDUCES CERVICAL SHORTENING INHIBITING CERVICAL INTERLEUKIN-1 SECRETION.
FABIO FACCHINETTI1, SIMONE PAGANELLI1, PAOLO VENTURINI1, GIULIA DANTE1, 1Universita` di Modena e Reggio Emilia, Modena, Italy
1:30
10
PROGESTERONE PROTECTS CHORION AND DECIDUA CELLS FROM CALCIUM INDUCED CELL DEATH IN PRIMARY CELL CULTURE
AMY MURTHA1, LIPING FENG1, BRYAN YONISH1, DAVID SCHOMBERG2, 1Duke University, Obstetrics and Gynecology, Durham, North Carolina 2Duke University, Cell Biology, Durham, North Carolina
1:45
11
THE EFFECT OF ANTEPARTUM PERIODONTAL THERAPY ON PRETERM BIRTH RATE ACCORDING TO CERVICAL LENGTH: A RANDOMIZED PILOT STUDY
SARAH SMITH1, ROBERT STRAUSS1, STEVEN OFFENBACHER2, KEVIN MOSS3, KIM BOGGESS1, SALLY TIMLIN4, JAMES BECK2, 1 University of North Carolina at Chapel Hill, Obstetrics/Gynecology, Chapel Hill, North Carolina 2University of North Carolina at Chapel Hill, Center for Oral and Systemic Diseases, Chapel Hill, North Carolina 3 University of North Carolina at Chapel Hill, Dental Ecology, Chapel Hill, North Carolina 4WakeMed, Obstetrics/Gynecology, Raleigh, North Carolina
2:00
12
NON-INVASIVE DIAGNOSIS OF INTRAAMNIOTIC INFECTION AND PRETERM BIRTH FROM PROTEOMIC ANALYSIS OF VAGINAL FLUID
JANE HITTI1, JODI LAPIDUS2, XINFANG LU3, LEONARDO PEREIRA4, DAVID ESCHENBACH1, MICHAEL GRAVETT5, SRINIVASA NAGALLA3, 1University of Washington, Obstetrics and Gynecology, Seattle, Washington 2Oregon Health & Science University, Public Health & Preventive Medicine, Portland, Oregon 3Oregon Health & Science University, Pediatrics, Portland, Oregon 4Oregon Health & Science University, Obstetrics and Gynecology, Portland, Oregon 5University of Washington, Obstetrics & Gynecology, Seattle, Washington
2:15
13
THE DIAGNOSTIC AND PROGNOSTIC VALUE OF MMP-8 PTD CHECK IN WOMEN WITH PRETERM PREMATURE RUPTURE OF MEMBRANES.
KUN WOO KIM1, HYUN SOO PARK1, SOON-SUP SHIM1, JONG KWAN JUN1, ROBERTO ROMERO2, BO HYUN YOON1, 1Seoul National University College of Medicine, Department of Obstetrics and Gynecology, Seoul, South Korea2Grosse pointe, Grosse pointe, Michigan
2:30
14
4-YEAR FOLLOW-UP OF CHILDREN EXPOSED TO 17ALPHA HYDROXYPROGESTERONE CAPROATE (17P) IN UTERO
ALLISON NORTHEN1, 1NICHD MFMU Network, Bethesda, Maryland
2:45
15
PROTEOMICS ANALYSIS OF AMNIOTIC FLUID. A NOVEL METHODOLOGY TO PROVIDE INSIGHT INTO THE MECHANISMS OF IDIOPATHIC PRETERM BIRTH
IRINA A. BUHIMSCHI1, VICTOR A. ROSENBERG1, SONYA S. ABDEL-RAZEQ1, STEPHEN F. THUNG1, CATALIN S. BUHIMSCHI1, 1Yale University, Ob./Gyn.&Reprod.Sci., New Haven, Connecticut
3:00
16
THE EFFECT OF ESTERASES ON 17HYDROXYPROGESTERONECAPROATE
RU YAN1, TATIANA NANOVSKAYA1, GARY HANKINS1, MAHMOUD AHMED1, 1University of Texas Medical Branch at Galveston, Obstetrics and Gynecology, Galveston, Texas
3:15
17
EX VIVO CYTOKINE PRODUCTION BY CELLS IN MID-TRIMESTER AMNIOTIC FLUID PREDICT SUBSEQUENT SPONTANEOUS PRETERM BIRTH (SPTB)
ANN MARIE BONGIOVANNI1, DEVRIM SEZEN1, CLAUDEL JEAN-PIERRE1, IARA LINHARES1, DANIEL SKUPSKI2, STEVEN WITKIN3, 1Weill Medical College of Cornell University, Obstetrics and Gynecology, New York, New York 2Cornell University, Obstetrics and Gynecology, Flushing, New York 3Cornell University, Obstetrics & Gynecology, New York, New York
XLIV December 2006
Thursday, February 8, 2007 1:15PM to 3:30PM
Oral Concurrent Session 2
Continental Ballroom 5
1:15
18
CHRONIC HYPOXIA INCREASES IL-6, TNF-, AND MATRIX METALLOPROTEINASES (MMP2 AND MMP9) EXPRESSION OF FETAL GUINEA PIG HEARTS
CHIEN OH1, YAFENG DONG2, LOREN THOMPSON1, 1University of Maryland at Baltimore, Obstetrics and Gynecology, Baltimore, Maryland 2 University of Kansas, Obstetrics and Gynecology, Kansas City, Kansas
1:30
19
PROTEOMIC ANALYSIS OF THE HUMAN AMNIOTIC FLUID (AF) TO PREDICT HISTOLOGICAL CHORIOAMNIONITIS (HCA) IN UTERO
IRINA A. BUHIMSCHI1, CHRISTIAN M. PETTKER1, LISSA K. MAGLOIRE1, STEPHEN F. THUNG1, GUOMAO ZHAO1, CAROLYN M. SALAFIA2, CATALIN S. BUHIMSCHI1, 1Yale University, Ob./ Gyn.& Reprod.Sci, New Haven, Connecticut 2Columbia University, Department of Epidemiology, Larchmont, New York
1:45
20
FETAL CORD BLOOD MONONUCLEAR CELLS COLLECTED AT TERM FROM HIV-1 INFECTED WOMEN HARBOR TRANSCRIPTIONALLY ACTIVE INTEGRATED HIV PROVIRAL DNA
JANE ELLIS1, GREG HAIR2, MICHAEL LINDSAY1, HARRIET WILLIAMS1, BRUCE SUNDSTROM2, 1Emory University, Department of Gynecology and Obstetrics, Atlanta, Georgia 2Emory University, Department of Pathology and Laboratory Medicine, Atlanta, Georgia
2:00
21
TLRS, THE LOWER GENITAL TRACT AND PREGNANCY
JUAN GONZALEZ1, JINGHUA CHAIR2, MICHAL ELOVITZ2, 1 Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 2 University of Pennsylvania, Philadelphia, Pennsylvania
2:15
22
THE CALCIUM BINDING PROTEIN S100, A MARKER FOR NEUROLOGIC INJURY IN THE PERINATAL PERIOD, IS INCREASED IN THE AMNIOTIC FLUID OF WOMEN WITH PRETERM LABOR AND INTACT MEMBRANES.
LARA FRIEL1, JIMMY ESPINOZA1, SAMUEL EDWIN2, JYH KAE NIEN2, RICARDO GOMEZ3, SONIA HASSAN1, TINNAKORN CHAIWORAPONGSA1, ROBERTO ROMERO2, 1Wayne State University School of Medicine, Department of Obstetrics and Gynecology, Detroit, Michigan 2Perinatology Research Branch, NICHD, NIH, DHHS, Detroit, Michigan 3CEDIP, Sotero del Rio Hospital, OB-GYN, Universidad Catolica de Chile, Puento Alto, Chile
2:30
23
PEPTIDE PROFILING OF MATERNAL SERUM TO DETECT SPONTANEOUS PRETERM BIRTH AND INTRA-AMNIOTIC INFECTION AMONG WOMEN IN PRETERM LABOR
LEONARDO PEREIRA1, JANE HITTI2, JODI LAPIDUS3, DAVID ESCHENBACH2, MICHAEL GRAVETT2, SRINIVASA NAGALLA4, 1 Oregon Health & Science University, Obstetrics and Gynecology, Portland, Oregon 2University of Washington, Obstetrics and Gynecology, Seattle, Washington 3Oregon Health & Science University, Public Health & Preventive Medicine, Portland, Oregon 4Oregon Health & Science University, Pediatrics, Portland, Oregon
2:45
24
PROTEIN EXPRESSION PROFILING OF EXTREMELY PRETERM PLACENTAS SUGGESTS DISTINCT PATHWAYS OF INTRAUTERINE INFLAMMATION
THOMAS MCELRATH1, RAINA FICHOROVA1, ELIZABETH ALLRED2, JONATHAN HECHT3, OLAF DAMMANN4, ALAN LEVITON2, 1Brigham and Women’s Hospital, Department of Obstetrics and Gynecology, Boston, Massachusetts 2Children’s Hospital of Boston, Neuroepidemiology Division, Boston, Massachusetts 3Beth Israel Deaconess Medical Center, Department of Pathology, Boston, Massachusetts 4Hannover Medical School, Neurology, Hannover, Germany
3:00
25
FETAL NUCLEATED RED BLOOD CELLS (NRBC) ARE REGULATED INDEPENDENTLY OF ERYTHROPOIETIN LEVELS IN A RAT MODEL OF INTRAUTERINE GROWTH RESTRICTION (IUGR)
VISWANATHAN RAVISHANKAR1, CATALIN S. BUHIMSCHI2, CARMEN BOOTH3, VINEET BHANDARI4, ERROL R. NORWITZ2, JOSHUA A. COPEL2, IRINA A. BUHIMSCHI2, 1State Univ. of NY, Ob./ Gyn.&Reprod. Med., Stony Brook, New York 2Yale University, Ob./ Gyn.&Reprod.Sci, New Haven, Connecticut 3Yale University, Comparative Medicine, New Haven, Connecticut 4Yale University, Pediatrics, New Haven, Connecticut
3:15
26
A ROLE FOR MICRORNAS – KEY REGULATORS OF GENE EXPRESSION – IN CHORIOAMNIONITIS AND PARTURITION
DANIEL MONTENEGRO1, ROBERTO ROMERO1, BETH L. PINELES1, ADI L TARCA2, YEON MEE KIM3, SORIN DRAGHICI2, JUAN PEDRO KUSANOVIC1, OFFER EREZ1, SHALI MAZAKITOVI4, SONIA HASSAN4, JIMMY ESPINOZA4, CHONG JAI KIM3, 1 Perinatology Research Branch, NICHD, NIH, DHHS, Detroit, Michigan 2 Wayne State University, Department of Computer Science, Detroit, Michigan 3Wayne State University School of Medicine, Department of Pathology, Detroit, Michigan 4Wayne State University School of Medicine, Department of Obstetrics and Gynecology, Detroit, Michigan
December 2006 XLV
Thursday, February 8, 2007 1:15PM to 3:30PM
Oral Concurrent Session 3
Continental Ballroom 6
1:15
27
REPEATED MEASURES SCREENING FOR TRISOMY 21 - RESULTS FROM A GENERAL POPULATION SCREENING TRIAL (THE FASTER TRIAL)
FERGAL D. MALONE1, DAVID WRIGHT2, HOWARD CUCKLE3, ROBERT H. BALL4, DAVID A. NYBERG5, CHRISTINE H. COMSTOCK6, GEORGE R. SAADE7, RICHARD L. BERKOWITZ8, SUSAN J. GROSS9, LORRAINE DUGOFF10, SABRINA D. CRAIGO11, ILAN E. TIMOR12, STEPHEN R. CARR13, HONOR M. WOLFE14, MARY E. D’ALTON15, 1Royal College of Surgeons in Ireland, Dublin, Ireland2University of Plymouth, Plymouth, United Kingdom3University of Leeds, Leeds, United Kingdom4University of California, San Francisco, California 5Swedish Medical Center, Seattle, Washington 6William Beaumont Hospital, Royal Oak, Michigan 7UTMB, Galveston, Texas 8 Mount Sinai Medical Center, New York, New York 9Albert Einstein College of Medicine, Bronx, New York 10University of Colorado Health Sciences Center, Denver, Colorado 11Tufts University, Boston, Massachusetts 12NYU Medical Center, New York, New York 13Brown University, Providence, Rhode Island 14University of North Carolina, Chapel Hill, North Carolina 15Columbia University, New York, New York
1:30
28
PREVENTION OF DEVELOPMENTAL DELAYS IN A DOWN SYNDROME MODEL
LAURA TOSO1, IRENE CAMERONI2, CECILIA SCHMIDT3, DANIEL ABEBE1, STEPHANIE BISSELL1, CATHERINE SPONG1, 1 National Institutes of Health (NIH), NICHD&NIAAA, Unit on Perinatal and Developmental Neurobiology, Bethesda, Maryland 2University of Milano-Bicocca, Obstetrics and Gynecology, Monza, Milan Italy3The Jackson Laboratory, Bar Harbor, Maine
1:45
29
NEUROPROTECTIVE PEPTIDES PREVENT THE ALCOHOL-INDUCED ALTERATION IN GABA-A3 WHICH PLAYS A ROLE IN CLEFT LIP AND PALATE IN FETAL ALCOHOL SYNDROME
LAURA TOSO1, DANIEL ABEBE1, ROBIN ROBERSON1, CATHERINE Y. SPONG1, 1National Institutes of Health (NIH), NICHD&NIAAA, Unit on Perinatal and Developmental Neurobiology, Bethesda, Maryland
2:00
30
TRENDS IN STATE/POPULATION-BASED DOWN SYNDROME (DS) SCREENING AND INVASIVE PRENATAL TESTING WITH THE INTRODUCTION OF FIRST TRIMESTER COMBINED DS SCREENING, SOUTH AUSTRALIA 1995-2004.
PETER MULLER1, CHRIS WILKINSON1, ROBERT COCCIOLONE2, RHONDA HUTCHINSON2, ERIC HAAN3, ANNABELLE CHAN4, 1 Women’s and Children’s Hospital, Perinatal Medicine, North Adelaide, South Australia Australia2Women’s and Children’s Hospital, Genetic Medicine, North Adelaide, South Australia Australia3Women’s and Children’s Hospital, Department of Genetic Medicine, Adelaide, South Australia Australia4Department of Health, Pregnancy Outcome Unit, Adelaide, South Australia Australia
2:15
31
FIRST-TRIMESTER RISK ASSESSMENT FOR TRISOMY 21 AND 18 IN TWIN PREGNANCY
STEPHEN CHASEN1, SRIRAM PERNI1, ROBIN B. KALISH1, FRANK A. CHERVENAK1, 1Weill Medical College of Cornell University, New York, New York
2:30
32
THE ROLE OF GENOME DAMAGE AND FOLATE NUTRIGENOMICS IN UTEROPLACENTAL INSUFFICIENCY (UPI)
DENISE FURNESS1, GUSTAAF DEKKER2, YEE KHONG3, BILL HAGUE4, MICHAEL FENECH5, 1CSIRO, Adelaide BC, South Australia Australia2Women’s and Children’s Hospital, Obstetrics and Gynaecology, North Adelaide, South Australia Australia3Women’s and Children’s Hospital, Adelaide, Obstetrics and Gynaecology, North Adelaide, South Australia Australia4Women’s and Children’s Hospital, Adelaide, North Adelaide, South Australia Australia5CSIRO, Human Nutrition, Adelaide, South Australia Australia
2:45
33
GENES IN GLUCOSE METABOLISM AND THEIR ASSOCIATION WITH SPINA BIFIDA
CHRISTINA DAVIDSON1, HOPE NORTHRUP2, TERRI KING2, JACK FLETCHER3, IRENE TOWNSEND3, GAYLE TYERMAN4, KIT SING AU2, 1University of Texas Health Science Center at Houston, Obstetrics, Gynecology and Reproductive Sciences, Houston, Texas 2 University of Texas Health Science Center at Houston, Pediatrics and Medical Genetics, Houston, Texas 3University of Houston-Texas Medical Center Annex, Psychology, Houston, Texas 4Shriners Hospitals for Children, Los Angeles, California
3:00
34
GENOMIC IMPRINTING DISORDERS AND BIRTH DEFECTS IN PREGNANCIES CONCEIVED WITH ASSISTED REPRODUCTIVE TECHNOLOGY (ART)
KATHERINE BIANCO1, MARY E NORTON1, VANESSA T ANGELES1, RENEE REIJO PERA1, 1University of California, San Francisco, Obstetrics, Gynecology and Reproductive Sciences, San Francisco, California
XLVI December 2006
3:15
35
EVIDENCE FOR A STEREOTYPIC DIFFERENCE IN POST-TRANSCRIPTIONAL REGULATION OF PLACENTAL GENE EXPRESSION IN PREECLAMPSIA AND SGA: AN EXPLANATION FOR THE TWO DIFFERENT PHENOTYPES?
BETH L. PINELES1, ROBERTO ROMERO1, DANIEL MONTENEGRO1, ADI L TARCA2, YU MI HAN1, YEON MEE KIM3, JUAN PEDRO KUSANOVIC1, POOJA MITTAL4, SONIA HASSAN4, JIMMY ESPINOZA4, CHONG JAI KIM3, 1Perinatology Research Branch, NICHD, NIH, DHHS, Detroit, Michigan 2Wayne State University, Department of Computer Science, Detroit, Michigan 3Wayne State University School of Medicine, Department of Pathology, Detroit, Michigan 4Wayne State University School of Medicine, Department of Obstetrics and Gynecology, Detroit, Michigan
December 2006 XLVII
Friday, February 9, 2007 Oral Plenary Session II (Fellows)
8:00AM to 10:00AM
Continental Ballroom 1-9
8:00
36
ADMINISTRATION OF CEFAZOLIN PRIOR TO SKIN INCISION IS SUPERIOR TO CEFAZOLIN AT CORD CLAMPING IN PREVENTING POSTCESAREAN INFECTIOUS MORBIDITY
SCOTT SULLIVAN1, TRIZ SMITH2, EUGENE CHANG1, THOMAS HULSEY3, J. VAN DORSTEN1, DAVID SOPER1, 1Medical University of South Carolina, Obstetrics and Gynecology, Charleston, South Carolina 2 Medical University of South Carolina, Obstetrics/Gynecology, Charleston, South Carolina 3Medical University of South Carolina, Pediatrics, Charleston, South Carolina
8:15
37
IMPACT OF INTERCONCEPTIONAL ANTIBIOTICS ON THE ‘‘ENDOMETRIAL FLORA’’
ALAN TITA1, SUE CLIVER1, ALICE GOEPFERT1, ROBERT GOLDENBERG1, MICHAEL CONNER2, WILLIAMS ANDREWS1, 1 University of Alabama at Birmingham, Obstetrics and Gynecology, Birmingham, Alabama 2University of Alabama at Birmingham, Pathology, Birmingham, Alabama
8:30
38
THE ROLE OF OXIDATIVE AND INFLAMMATORY STRESS IN THE DEVELOPMENTAL ORIGIN OF ADULT VASCULAR DYSFUNCTION
LABIB GHULMIYYAH1, SHANNON CLARK1, AMANDA MARETH1, PHYLLIS GAMBLE1, GARY DV HANKINS1, GARLAND D ANDERSON1, GEORGE SAADE1, MONICA LONGO1, 1University of Texas Medical Branch, Obstetrics & Gynecology/Maternal Fetal Medicine, Galveston, Texas
8:45
39
CHANGES IN CELLULAR CHOLESTEROL METABOLISM ARE ASSOCIATED WITH FETAL PROGRAMMING OF ATHEROSCLEROSIS.
NIMA GOHARKHAY1, KARINA VILLARREAL1, SERGIO RODRIGUEZ1, AMANDA MARETH1, KENDRA STISSER2, ESTHER TAMAYO1, PHYLLIS GAMBLE1, MICHEL MAKHLOUF1, GARLAND D ANDERSON1, MONICA LONGO1, GEORGE SAADE1, 1 University of Texas Medical Branch, Obstetrics & Gynecology/Maternal Fetal Medicine, Galveston, Texas 2University of Texas Medical Branch, Obstetrics & Gynecology/Gynecologic Oncology, Galveston, Texas
9:00
40
SYNCYTIOTROPHOBLASTS OF PREECLAMPTIC PLACENTAS OVEREXPRESS CORTICOTROPINRELEASING HORMONE MRNA
LYDIA LEE1, FERNANDA HEITOR2, HARVEY KLIMAN3, THOMAS MCELRATH1, JOSEPH MAJZOUB2, 1Harvard University, Department of Obstetrics and Gynecology, Boston, Massachusetts 2 Children’s Hospital of Boston, Endocrinology, Boston, Massachusetts 3 Yale University, Obstetrics & Gynecology, New Haven, Connecticut
9:15
41
HYPOXIA ENHANCES DEPOSITION OF THE C5B-9 MEMBRANE ATTACK COMPLEX OF COMPLEMENT ON HUMAN TROPHOBLASTS
ROXANE RAMPERSAD1, AARON BARTON1, YOEL SADOVSKY2, D. NELSON1, 1Washington University in St. Louis, Obstetrics & Gynecology, St. Louis, Missouri 2Washington University in St. Louis, Cell Biology & Physiology, St. Louis, Missouri
9:30
42
PLACENTAL GENE TRANSFER OF IGF-1 CORRECTS FETAL GROWTH RESTRICTION
URSULA HARKNESS1, JIGNESH PARVADIA1, MARIA RIPBERGER1, SACHIN VAIKUNTH1, EVA UZVOLGYI1, DATIS ALAEE1, A. MARWAN1, BARBARA KALINOWSKA1, ARTURO MALDONADO1, SUZI DEMIRBAG1, TIMOTHY CROMBLEHOLME1, 1Cincinnati Children’s Hospital Medical Center, Center for Molecular Fetal Therapy, University of Cincinnati, Cincinnati, Ohio
9:45
43
GENOMIC DNA METHYLATION PATTERNS ARE FUNCTIONALLY ALTERED AMONG OFFSPRING IN A NON-HUMAN PRIMATE MODEL OF MATERNAL OBESITY
KJERSTI AAGAARD-TILLERY1, ROBERT MCKNIGHT2, ANDRZEJ POPLAWSKI3, JAN DUMANSKI3, ROBERT SILVER1, KEVIN GROVE4, ROBERT LANE2, 1University of Utah, Obstetrics and Gynecology, Salt Lake City, Utah 2University of Utah, Division of Neonatology, Salt Lake City, Utah 3University of Alabama at Birmingham, Genetics, Birmingham, Alabama 4Oregon Health & Science University, ONPRC Research Neuro, Portland, Oregon
XLVIII December 2006
Friday, February 9, 2007 1:15PM to 3:30PM
Oral Concurrent Session 4
Continental Ballroom 4
1:15
44
NIH SPONSORED PROSPECTIVE RANDOMIZED CLINICAL TRIAL OF AMNIOREDUCTION VS SELECTIVE FETOSCOPIC LASER PHOTOCOAGULATION FOR TWIN-TWIN TRANSFUSION SYNDROME
TIMOTHY CROMBLEHOLME1, DAVID SHERA2, FLINT PORTER3, HANMIN LEE4, CHYU JACQUELYN5, RICHARD K. SILVER6, ALFRED ABUHAMAD7, MARK JOHNSON8, GEORGE R. SAADE9, MARY D’ALTON10, LARRY SHIELDS11, KAUFFMAN DAVID12, JOANNE STONE13, JEFFREY LIVINGSTON14, WILLIAM POLZIN15, ROBERT LORENZ16, BRUCE YOUNG17, DAVID A. MILLER18, ANTHONY ODIBO19, JACK RYCHIK20, LYNN SIMPSON21, VICKIE FELDSTEIN22, BEVERLY COLEMAN23, EDUARDO RUCHELLI24, LARISSA BILANIUK25, ERIN SIMON25, BETTY VOHR26, ISTVAN SERI27, 1Cincinnati Children’s Hospital Medical Center, Fetal Care Center, Cincinnati, Ohio 2Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania 3University of Utah, Perinatology, Salt Lake City, Utah 4 University of California, San Francisco, Surgery, Pediatrics, & OB/GYN, San Francisco, California 5University of Colorado Health Sciences Center, Denver, Colorado 6Evanston Hospital, Obstetrics and Gynecology, Evanston, Illinois 7Eastern Virginia Medical School, Obstetrics And Gynecology, Norfolk, Virginia 8Children’s Hospital of Philadelphia, Center for Fetal Diagnosis & Treatment, Philadelphia, Pennsylvania 9University of Texas Medical Branch at Galveston, Obstetrics & Gynecology, Galveston, Texas 10Columbia University, Obstetrics and Gynecology, New York, New York 11University of Washington, Obstetrics and Gynecology, Seattle, Washington 12Magee-Women’s Hospital, Pittsburgh, Pennsylvania 13 Mount Sinai School of Medicine, Obstetrics or Gynecology, New York, New York 14University of Cincinnati, Fetal Care Center, Obstetrics and Gynecology, Cincinnati, Ohio 15Good Samaritan Hospital, Cincinnati, Ohio 16Willam Beaumont Hospital, Royal Oak, Michigan 17New York University, Obstetrics and Gynecology, New York City, New York 18Queen of Angels Hollywood Presbyterian Medical Center, Obstetrics and Gynecology/MFM, Los Angeles, California 19University of Pennsylvania Medical Center, Obstetrics & Gynecology, Philadelphia, Pennsylvania 20 Children’s Hospital of Philadelphia, Fetal Heart Program, Philadelphia, Pennsylvania 21Columbia University, Faculty of Medicine, Briarcliff Manor, New York 22University of California, San Francisco, Radiology, San Francisco, California 23Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 24Children’s Hospital of Philadelphia, Pathology Department, Philadelphia, Pennsylvania 25Children’s Hospital of Philadelphia, Department of Radiology, Philadelphia, Pennsylvania 26 Brown University, Pediatrics, Providence, Rhode Island 27University of Southern California, Los Angeles, California
1:30
45
MATERNAL HYPEROXYGENATION TEST IN FETUSES WITH PRENATALLY TREATED SEVERE DIAPHRAGMATIC HERNIA: LONGITUDINAL OBSERVATION STUDY.
ELISA DONE’1, JACQUES JANI1, DOMINIQUE VAN SCHOUBROECK1, ANNE DEBEER2, JAN DEPREST1, 1University Hospital Leuven Belgium, Obstetrics and Gynecology, Leuven, Belgium2University Hospital Leuven Belgium, Neonatology, Leuven, Belgium
1:45
46
RISK OF BIRTH DEFECTS IN PREGNANCIES ASSOCIATED WITH ASSISTED REPRODUCTIVE TECHNOLOGY
DARINE EL-CHAAR1, QIUYING YANG2, JIM BOTTOMELY3, SHI WU WEN2, MARK WALKER2, 1University of Ottawa, Obstetrics and Gynecology, Ottawa, Ontario Canada2OMNI Research Group, Ottawa Health Research Institute, Ottawa, Ontario Canada3Perinatal Partnership of Eastern Ontario, Ottawa, Ontario Canada
2:00
47
LOWER EXTREMITY NEUROMOTOR FUNCTION FOLLOWING IN UTERO MYELOMENINGOCELE REPAIR
ENRICO DANZER1, SCOTT ADZICK1, MARSHA GERDES1, MICHAEL BEBBINGTON1, LESLIE SUTTON1, JEANNE MELCHIONNI1, MARK JOHNSON1, 1Children’s Hospital of Philadelphia, Center for Fetal Diagnosis and Treatment, Philadelphia, Pennsylvania
2:15
48
LONG TERM PULMONARY GENE THERAPY WITH A LENTIVIRAL VECTOR IN A FETAL RAT MODEL.
JAAN TOELEN1, GIJSBERS RIK1, LOURENc¸O SBRAGIA1, DEROOSE CHRISTOPHE1, ZEGER DEBYSER1, JAN DEPREST2, 1 Catholic University of Leuven, Molecular Virology and Gene Therapy, Leuven, Belgium2University Hospital Leuven Belgium, Leuven, Brabant Belgium
December 2006 XLIX
2:30
49
VALIDATION OF THE NEONATAL ENCEPHALOPATHY COMMITTEE OPINION IN ACUTELY ASPHYXIATED NEONATES WITH PERMANENT BRAIN INJURY
JEFFREY PHELAN1, LISA MARIE KORST2, GILBERT I. MARTIN3, 1 Citrus Valley Medical Center, OB/GYN, West Covina, California 2USC Keck School of Medicine, OB/Gyn, Women’s & Children’s Hospital, Los Angeles, California 3Citrus Valley Medical Center, Neonatology, West Covina, California
2:45
50
PROGNOSTIC VALUE OF AMNIOTIC FLUID BRAIN NATRIURETIC PEPTIDE (BNP) IN FETAL AORTIC STENOSIS
WALTER LUBBERS1, DAWN BURMAN1, SCOTT BAKER1, PIROOZ EGHTESADY1, 1Children’s Hospital Medical Center of Cincinnati, Cardiothoracic Surgery, Cincinnati, Ohio
3:00
51
A RANDOMIZED PROSPECTIVE TREATMENT TRIAL FOR PATIENTS WITH ‘‘STANDARD RISK’’ ALLOIMMUNE THROMBOCYTOPENIA (AIT)
RICHARD BERKOWITZ1, JAMES B. BUSSEL2, CRYSTAL HUNG3, MEGAN WISSERT3, 1Columbia Presbyterian Medical Center, New York, New York 2New York Weill Cornell Medical Center, Pediatric Hematology, New York, New York 3Cornell University, Department of Pediatric Hematology, New York, New York
3:15
52
A MURINE MODEL OF FETAL PROGRAMMING OF ATHEROSCLEROSIS: MORPHOLOGIC AND HISTOLOGIC CHARACTERIZATION
NIMA GOHARKHAY1, FANGXIAN LU1, ELENA SBRANA2, PHYLLIS GAMBLE1, ANCIZAR BETANCOURT1, ESTHER TAMAYO1, KARINA VILLARREAL1, GARY DV HANKINS1, MONICA LONGO1, GEORGE R SAADE1, 1University of Texas Medical Branch, Obstetrics & Gynecology/Maternal Fetal Medicine, Galveston, Texas 2University of Texas Medical Branch, Pathology, Galveston, Texas
L December 2006
Friday, February 9, 2007 1:15PM to 3:30PM
Oral Concurrent Session 5
Continental Ballroom 5
1:15
53
THE RELATIONSHIP BETWEEN CHANGES IN PREPREGNANCY BMI BETWEEN PREGNANCIES AND INDICATIONS FOR PRIMARY CESAREAN DELIVERY.
DARIOS GETAHUN1, LILLIAN KAMINSKY1, DENISE ELSASSER1, RUSSELL KIRBY2, CANDE ANANTH1, ANTHONY VINTZILEOS1, 1 University of Medicine and Dentistry of New Jersey, Obstetrics, Gynecology and Reproductive Sciences, New Brunswick, New Jersey 2 University of Alabama at Birmingham, School of Public Health, Birmingham, Alabama
1:30
54
MCDONALD VS. SHIRODKAR: OUTCOMES IN THE EXPECTANT MANAGEMENT COMPARED TO PHYSICAL EXAM-INDICATED CERCLAGE (EMPEC) INTERNATIONAL COHORT STUDY
PATRICIA ROBERTSON1, SURASITH CHAITHONGWONGWATTHANA2, SEAN DALY3, LEONARDO PEREIRA1, JUHA RASANEN4, AMANDA COTTER5, WITOON PRASERTCHAROENSUK6, RICARDO GOMEZ7, SUNEETA MITTAL8, VINCENZO BERGHELLA9, S. LIMPONGSANURAK10, JORGE E. TOLOSA1, 1Oregon Health & Science University, Global Network for Perinatal and Reproductive Health, Obstetrics and Gynecology, Portland, Oregon 2Chulalongkorn University, Department of Obstetrics and Gynecology, Bangkok, Thailand3Coombe Women´s Hospital, Dublin, Ireland4University of Oulu, Obstetrics and Gynecology, Oulu, Finland5University of Miami, Obstetrics and Gynecology, Miami, Florida 6Khon Kaen University, Khon Kaen, Thailand7CEDIP, Sotero del Rio Hospital, Puente Alto, Chile8All India Institute of Medical Sciences, New Delhi, India9Thomas Jefferson University, Obstetrics and Gynecology, Philadelphia, Pennsylvania 10Chulalongkorn University, Obstetrics & Gynecology, Bangkok, Thailand
1:45
55
MATERNAL SMOKING AND DECREASED 5METHYLTETRAHYDROFOLATE IN UMBILICAL CORD PLASMA
ROBERT SOKOL1, ROBERT PAWLOSKY2, JOHN HANNIGAN3, KEN STARK4, NORMAN SALEM5, 1Wayne State University, Obstetrics/ Gynecology, Detroit, Michigan 2National Institute on Alcohol Abuse and Alcoholism, Division of Intramural Clinical and Biological Research, Bethesda, Maryland 3Wayne State University, Obstetrics and Gynecology, Detroit, Michigan 4University of Waterloo, Kinesiology, Waterloo, Ontario Canada5National Institutes of Health (NIH), hn556, Rockville, Maryland
2:00
56
INCREASED RECURRENCE OF PRETERM DELIVERY WITH EARLY CESSATION OF 17 ALPHA-HYDROXYPROGESTERONE CAPROATE
ANDREI REBARBER1, LAUREN FERRARA1, MARY ELLEN HANLEY2, NIKI ISTWAN3, DEBBIE RHEA3, GARY STANZIANO3, DANIEL SALTZMAN1, 1Mount Sinai School of Medicine, Maternal Fetal Medicine, New York, New York 2Valley Hospital, Maternal Fetal Medicine, Paramus, New Jersey 3Matria Healthcare, Clinical Research, Marietta, Georgia
2:15
57
THE ROLE OF PROTEASE ACTIVATED RECEPTOR 1 (PAR1) THROMBIN RECEPTOR POLYMORPHISMS IN RECURRENT PREGNANCY LOSS (RPL) - NOT ONLY COAGULATION
ARON TEVET1, GEONA ALTARESCU2, EHUD MARGALIOT3, ARNON SAMUELOFF4, RACHEL BAR-SHAVIT5, SORINA GRANOVSKY-GRISARU6, 1Shaare Zedek Medical Center, Jerusalem, Obstetrics and Gynecology, Jerusalem, Israel2Shaare Zedek Medical Center, Genetics, Jerusalem, Israel3Shaare Zedek Medical Center, Obstetrics Gynecology, Jerusalem, Israel4Shaare Zedek Medical Center, Obstetrics and Gynecology, affiliated with Ben-Gurion University of the Negev, BeerSheva, Jerusalem, Israel5Tumor Biology, Hadassah Hospital and the Hebrew University, Jerusalem, Oncology&Tumor Biology, Jerusalem, Israel6Shaare Zedek Medical Center, Obsterics Gynecology, Jerusalem, Israel
2:30
58
BIRTH ORDER OF TWINS AND THE RISK OF DELIVERY RELATED PERINATAL DEATH IN ENGLAND, NORTHERN IRELAND AND WALES, 1994-2003.
GORDON SMITH1, KATE FLEMING2, IAN WHITE3, 1University of Cambridge, Obstetrics & Gynaecology, Cambridge, United Kingdom2Confidential Enquiry into Maternal and Child Health, London, United Kingdom3MRC Biostatistics Unit, Cambridge, UK, Cambridge, United Kingdom
2:45
59
WHEN SHOULD WOMEN WITH PLACENTA PREVIA BE DELIVERED?: A DECISION ANALYSIS
MARYA ZLATNIK1, SARAH LITTLE1, PUJA KOHLI1, NAOMI STOTLAND1, ANJALI KAIMAL1, AARON CAUGHEY1, 1University of California, San Francisco, Obstetrics, Gynecology and Reproductive Sciences, San Francisco, California
December 2006 LI
3:00
60
A PROSPECTIVE, RANDOMIZED TRIAL OF TRANSCERVICAL FOLEY CATHETER WITH OR WITHOUT OXYTOCIN FOR PREINDUCTION CERVICAL RIPENING
CHRISTIAN M. PETTKER1, SEAN B. POCOCK2, DOROTHY P. SMOK2, PATRICIA C. DEVINE2, 1Yale University, Obstetrics, Gynecology, and Reproductive Sciences, New Haven, Connecticut 2 Columbia University Medical Center, Division of Maternal-Fetal Medicine, Department of Obstetrics & Gynecology, New York, New York
3:15
61
DESCRIPTIVE STUDY OF POSTPARTUM HEADACHE
CAROLINE STELLA1, CHRISTIANO JODICKE1, HELEN HOW1, URSULA HARKNESS1, BAHA SIBAI1, 1University of Cincinnati, Obstetrics & Gynecology, Cincinnati, Ohio
LII December 2006
Friday, February 9, 2007 1:15PM to 3:30PM
Oral Concurrent Session 6
Continental Ballroom 6
1:15
62
NEONATAL OUTCOME IN MONOCHORIONIC TWINS WITH TWIN-TO-TWIN TRANSFUSION SYNDROME FOLLOWING INTRAUTERINE TREATMENT WITH AMNIOREDUCTION OR FETOSCOPIC LASER SURGERY: COMPARISON WITH DICHORIONIC TWINS MATCHED FOR GESTATIONAL AGE
LENCLEN RICHARD1, CIARLO GIUSEPPINA1, PAUPE ALAIN1, ORTQVIST LISA2, VILLE YVES2, 1Centre Hospitalier Poissy-St Germain, Neonatology, Poissy, France2Centre Hospitalier Poissy-St Germain, Fetal Medicine, Obstetrics, Poissy, France
1:30
63
THE EFFECT OF THE POSTNATAL ENVIRONMENT ON ALTERED FETAL PROGRAMMING OF ADULT VASCULAR FUNCTION
SHANNON CLARK1, MICHEL MAKHLOUF1, GARY DV HANKINS1, GARLAND D ANDERSON1, GEORGE SAADE1, MONICA LONGO1, 1University of Texas Medical Branch, Obstetrics & Gynecology/Maternal Fetal Medicine, Galveston, Texas
1:45
64
PROSPECTIVE CARDIAC MONITORING IN FETUSES AT RISK OF CONGENITAL HEART BLOCK: THE PR INTERVAL & DEXAMETHASONE EVALUATION (PRIDE) STUDY
JOSHUA COPEL1, DEBBIE FRIEDMAN2, MIMI KIM3, CLAUDINE DAVIS4, JILL BUYON4, 1Yale University, Obstetrics & Gynecology, New Haven, Connecticut 2Saint Barnabas Medical Center, Pediatric Cardiology, Livingston, New Jersey 3Albert Einstein College of Medicine, New York, New York 4New York University, Medicine / Rheumatology, New York, New York
2:00
65
DUCTUS VENOSUS VELOCIMETRY IN FETAL HYPOXIA AND ACIDEMIA
KAARIN MAKIKALLIO1, GANESH ACHARYA2, TIINA ERKINARO3, MERVI HAAPSAMO1, TOMI KAVASMAA3, JAMES HUHTA2, JUHA RASANEN1, 1University of Oulu, Obstetrics and Gynecology, Oulu, Finland2University of South Florida, Pediatrics, St. Petersburg, Florida 3University of Oulu, Anesthesiology, Oulu, Finland
2:15
66
TERBUTALINE VERSUS NITROGLYCERIN FOR ACUTE INTRAPARTUM FETAL RESUSCITATION
KRISTIN PULLEN1, LARISA TAYLOR1, SARAH WALLER1, ELIZABETH LANGEN1, MAURICE DRUZIN1, EDWARD RILEY2, AARON CAUGHEY3, YASSER EL-SAYED1, 1Stanford University, Obstetrics and Gynecology, Stanford, California 2Stanford University, Anesthesia, Stanford, California 3University of California, San Francisco, Obstetrics, Gynecology, and Reproductive Sciences, San Francisco, California
2:30
67
THE EFFECT OF ORAL EVENING PRIMROSE OIL ON BISHOP SCORE AND CERVICAL LENGTH AMONG TERM GRAVIDAS
KAREN ALESSANDRA TY-TORREDES1, 1Our Lady of Lourdes Hospital, Obstetrics and Gynecology, Manila, Philippines
2:45
68
A RANDOMIZED CONTROLLED TRIAL OF TRANSCERVICAL FOLEY CATHETER WITH AND WITHOUT EXTRA-AMNIOTIC SALINE INFUSION (EASI) FOR LABOR INDUCTION
MONIQUE LIN1, MATTHEW TREASTER2, KIMBERLY REID3, FRANCIS NUTHALAPATY4, PATRICK RAMSEY5, GEORGE LU6, 1 University of Alabama at Birmingham, Obstetrics and Gynecology, Birmingham, Alabama 2University of Missouri-Kansas City, Department of Obstetrics and Gynecology, Kansas City, Missouri 3St. Lukes Hospital of Kansas City, Kansas City, Missouri 4University of Alabama at Birmingham, Obstetrics & Gynecology, Greenville, South Carolina 5 University of Alabama at Birmingham, Obstetrics/Gynecology, Birmingham, Alabama 6Obstetrix Medical Group of Kansas & Missouri, Kansas City, Missouri
3:00
69
GENE EXPRESSION SIGNATURE PATHWAYS IN THE HUMAN UTERINE CERVIX BEFORE AND AFTER SPONTANEOUS TERM PARTURITION
SONIA HASSAN1, ROBERTO ROMERO2, ADI L TARCA3, SORIN DRAGHICI3, NAHLA KHALEK1, NATALIA CAMACHO1, POOJA MITTAL1, BO HYUN YOON4, JIMMY ESPINOZA1, YORAM SOROKIN1, JOHN MALONE, JR.1, 1Wayne State University School of Medicine, Department of Obstetrics and Gynecology, Detroit, Michigan 2 Perinatology Research Branch, NICHD, NIH, DHHS, Detroit, Michigan 3 Wayne State University, Department of Computer Science, Detroit, Michigan 4Seoul National University College of Medicine, Department of Obstetrics and Gynecology, Seoul, South Korea
3:15
70
PHARMACOGENOMICS OF MATERNAL TOBACCO USE: METABOLIC GENE POLYMORPHISMS MODIFY RISK OF ADVERSE PREGNANCY OUTCOMES
KJERSTI AAGAARD-TILLERY1, 1for the NICHD MFMU Network, Bethesda, Maryland
December 2006 LIII
Saturday, February 10, 2007 8:00AM to 10:00AM
Oral Concurrent Session 7
Continental Ballroom 4
8:00
71
PARADOXIC INCREASE IN GLOMERULAR NUMBER OF OFFSPRING EXPOSED TO MATERNAL HYPERNATREMIA
ROY Z. MANSANO1, MINA DESAI1, AMBICA GARG1, GYU YEON CHOI1, MICHAEL ROSS1, 1Harbor-UCLA Med. Ctr. (LA BioMed), Dept. of Ob/Gyn, Torrance, California
8:15
72
PGE2 INDUCED CERVICAL RIPENING MODULATES PROTEOGLYCAN EXPRESSION
TANYA DAILEY1, HUILING JI1, VIT LONG1, DJURO JOSIC2, EDWARD K CHIEN1, 1Brown University, Women & Infants Hospital of Rhode Island, Providence, Rhode Island 2Brown University, Pathology, Providence, Rhode Island
8:30
73
PROGRAMMED HEPATIC LIPID DYSREGULATION IS INDEPENDENT OF OBESITY
GYU YEON CHOI1, AMBICA GARG1, ROY Z. MANSANO1, MICHAEL ROSS1, MINA DESAI1, 1Harbor-UCLA Med. Ctr. (LA BioMed), Dept. of Ob/Gyn, Torrance, California
8:45
74
UNIQUE REGULATORY LYMPHOCYTE IN FIRST TRIMESTER HUMAN DECIDUA
HAGAI AMSALEM1, ANAT GAIGER2, SAHAR MIZEACHI3, SIMCHA YAGEL1, JACOB RACHMILEWITZ2, 1Departments of Obstetrics & Gynecology, Hebrew University Hadassah Medical Center, Jerusalem, Israel2Hadassah University Hospital Jerusalem, Goldyne Savad Institute of Gene Therayp, jerusalem, Israel3Hadassah University Hospital Jerusalem, The Lautenberg Center for General and Tumor Immunology, Jerusalem, Israel
9:00
75
DEVELOPMENTAL ENHANCEMENT IN THE NEONATAL PERIOD IN HEALTHY MICE
LAURA TOSO1, IRENE CAMERONI2, DANIEL ABEBE1, CATHERINE SPONG1, 1Unit on Perinatal and Developmental Neurobiology, NICHD&NIAAA, National Institute of Health (NIH), Bethesda, Maryland 2University of Milano-Bicocca, Obstetrics and Gynecology, Monza, Milan Italy
9:15
76
FETAL PROGRAMMING OF BLOOD PRESSURE IN A TRANSGENIC MOUSE MODEL OF ALTERED INTRAUTERINE ENVIRONMENT
MONICA LONGO1, FANGXIAN LU1, ESTHER TAMAYO1, PHYLLIS GAMBLE1, GARLAND D ANDERSON1, GARY DV HANKINS1, GEORGE SAADE1, 1University of Texas Medical Branch, Obstetrics & Gynecology/Maternal Fetal Medicine, Galveston, Texas
9:30
77
MULTI-DRUG RESISTANCE RECEPTORS REGULATE TRANSMISSION OF THERAPEUTIC AGENTS ACROSS THE PLACENTA
SAMUEL PARRY1, JIAN ZHANG1, 1University of Pennsylvania, Obstetrics and Gynecology, Philadelphia, Pennsylvania
9:45
78
DURATION OF LACTATION AND INCIDENCE OF MYOCARDIAL INFARCTION
ALISON STUEBE1, KARIN MICHELS1, WALTER WILLETT2, JOANN MANSON3, JANET RICH-EDWARDS3, 1Brigham and Women’s Hospital, Harvard Medical School, Department of Obstetrics and Gynecology, Boston, Massachusetts 2Harvard School of Public Health, Boston, Massachusetts 3Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
LIV December 2006
Saturday, February 10, 2007 8:00AM to 10:00AM
Oral Concurrent Session 8
Continental Ballroom 6
8:00
79
TREATMENT OF GESTATIONAL DIABETES MELLITUS: ORAL HYPOGLYCEMIC AGENTS COMPARED TO SUBCUTANEOUS INSULIN THERAPY
YVONNE CHENG1, JUDITH CHUNG2, INGRID BLOCKKURBISCH1, MARIBETH INTURRISI3, AARON CAUGHEY1, 1 University of California, San Francisco, Department of Obstetrics, Gynecology and Reproductive Sciences, San Francisco, California 2 University of California, Irvine, Obstetrics and Gynecology, Orange, California 3University of California, San Francisco, School of Nursing, San Francisco, California
8:15
80
IN UTERO PROGRAMMING OF VASCULAR FUNCTION IN THE GESTATIONAL DIABETIC (LEPR/D) DB MOUSE.
MICHEL MAKHLOUF1, ESTHER TAMAYO1, PHYLLIS GAMBLE1, GARLAND D ANDERSON1, GEORGE SAADE1, MONICA LONGO1, 1 University of Texas Medical Branch, Obstetrics & Gynecology/Maternal Fetal Medicine, Galveston, Texas
8:30
81
PODOCYTURIA IS A SENSITIVE AND SPECIFIC MARKER FOR PREECLAMPSIA
DAVID ROSENTHAL1, BRIAN BROST2, WILLIAM WATSON2, LARISA GAVRILOVA3, STEPHEN TURNER4, JOSEPH GRANDE5, VESNA GAROVIC6, 1Mayo Foundation for Medical Education and Research, Nephrology and Hypertension, Rochester, Minnesota 2Mayo Clinic College of Medicine, Maternal Fetal Medicine Division, Rochester, Minnesota 3Mayo Clinic College of Medicine, Rochester, Minnesota 4Mayo Foundation for Medical Education and Research, Internal Medicine, Rochester, Minnesota 5Mayo Foundation for Medical Education and Research, Pathology, Rochester, Minnesota 6Mayo Clinic College of Medicine, Nephrology and Hypertension, Rochester, Minnesota
8:45
82
IDENTIFICATION OF SFLT1 POLYA SIGNAL SEQUENCES AND MAPPING INTRONIC CISELEMENTS THAT REGULATE SFLT1 IN HUMAN PLACENTA.
CHRISTIE THOMAS1, KANG ZIU LIU2, 1University of Iowa and Department of Veterans Affairs, Internal Medicine & Molecular Biology, Iowa City, Iowa 2University of Iowa, Internal Medicine, Iowa City, Iowa
9:00
83
IN VITRO VASCULAR REACTIVITY IN A MOUSE MODEL OF PREECLAMPSIA INDUCED BY OVEREXPRESSION OF SFLT-1
FANGXIAN LU1, MONICA LONGO1, PHYLLIS GAMBLE1, ESTHER TAMAYO1, GARLAND D ANDERSON1, GARY DV HANKINS1, GEORGE SAADE1, 1University of Texas Medical Branch, Obstetrics & Gynecology/Maternal Fetal Medicine, Galveston, Texas
9:15
84
HUMAN HTRA1 RETARDS JEG-3 CHORIOCARCINOMA CYTOTROPHOBLAST INVASION IN VITRO
FUNMINIYI AJAYI1, VIJI SHRIDHAR2, BRIAN BROST1, WILLIAM WATSON1, JEREMY CHIEN2, 1Mayo Clinic College of Medicine, Maternal Fetal Medicine Division, Rochester, Minnesota 2Mayo Clinic College of Medicine, Pathology and Laboratory Medicine, Rochester, Minnesota
9:30
85
EFFECT OF SUBSEQUENT PREGNANCY ON VASCULAR FUNCTION IN ENDOTHELIAL NITRIC OXIDE SYNTHASE (NOS3) KNOCKOUT MICE
LABIB GHULMIYYAH1, SHANNON CLARK1, ESTHER TAMAYO1, PHYLLIS GAMBLE1, GARY HANKINS DV1, GARLAND D ANDERSON1, GEORGE SAADE1, MONICA LONGO1, 1University of Texas Medical Branch, Obstetrics & Gynecology/Maternal Fetal Medicine, Galveston, Texas
9:45
86
CIRCULATING ANGIOGENIC FACTORS IN SMOKERS AND NON-SMOKERS DURING NORMOTENSIVE PREGNANCY
RICHARD LEVINE1, CONG QIAN2, KAI YU1, BAHA SIBAI3, ANANTH KARUMANCHI4, 1Department of Health and Human Services, National Institute of Child Health and Human Development, Division of Epidemiology, Statistics, and Prevention Research, Bethesda, Maryland 2Allied Technology Group, Rockville, Maryland 3University of Cincinnati, Obstetrics and Gynecology, Cincinnati, Ohio 4Center for Vascular Biology, Division of Nephrology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts
December 2006 LV
Oral Plenary Session I
Continental Ballroom 1-9
8:00
1
A RANDOMIZED CONTROLLED TRIAL OF 17-HYDROXYPROGESTERONE CAPROATE (17-OHPC) FOR THE PREVENTION OF PRETERM BIRTH IN TWINS
STEVE CARITIS1, DWIGHT ROUSE1, 1NICHD MFMU Network, Bethesda, Maryland
8:15
2
LONG TERM FOLLOW-UP OF INFANTS RECEIVING SINGLE VS REPEAT COURSES OF ANTENATAL CORTICOSTEROIDS (ACS) FROM THE MFMU RCT
RONALD WAPNER1, 1NICHD MFMU Network, Bethesda, Maryland
8:30
3
PERI-OPERATIVE PROGNOSTIC FACTORS IN TWIN-TO-TWIN TRANSFUSION SYNDROME TREATED BY FETOSCOPIC LASER OCCLUSION OF CHORIONIC PLATE ANASTOMOSES
JULIEN STIRNEMANN1, SYLVIE CHEVRET2, LAURENCE BUSSIERES3, YVES VILLE4, 1CHI Poissy Saint Germain, Paris, France2Universite´ Paris 7, INSERM 444, Statistics, Paris, France3De´le´gation Re´gionale a` la Recherche Clinique, Hopital Saint-Louis, Clinical Research, Paris, France4Universite´ Paris Ouest UVSQ, CHI Poissy Saint Germain en Laye, Paris, France
8:45
4
COMPREHENSIVE PROTEOMIC ANALYSIS OF HUMAN CERVICAL-VAGINAL FLUID AND IDENTIFICATION OF NOVEL BIOMARKERS FOR PREDICTION OF SPONTANEOUS PRETERM BIRTH
LEONARDO PEREIRA1, JODI LAPIDUS2, XINFANG LU3, MICHAEL GRAVETT4, SRINIVASA NAGALLA3, 1Oregon Health & Science University, Obstetrics and Gynecology, Portland, Oregon 2Oregon Health & Science University, Public Health & Preventive Medicine, Portland, Oregon 3Oregon Health & Science University, Pediatrics, Portland, Oregon 4University of Washington, Obstetrics and Gynecology, Seattle, Washington
9:00
5
LONG-TERM NEURODEVELOPMENTAL OUTCOME IN TWIN-TO-TWIN TRANSFUSION SYNDROME IN THE EUROFOETUS TRIAL
LISA O¨RTQVIST1, SYLVIE CHEVRET2, LAURENCE BUSSIERES3, STEPHANIE STARACI1, FABIENNE HUARD1, YVES VILLE1, 1ParisOuest University VSQ, Department of Gynecology and Obstetrics, Paris, France2Universite´ Paris 7, INSERM 444, Statistics, Paris, France3De´le´gation Re´gionale a` la Re´cherche Clinique, Hopital Saint-Louis, Clinical Research, Paris, France
9:15
6
THE EFFECT OF SFLT-1 OVER-EXPRESSION IN PREGNANT MICE ON BLOOD PRESSURE OF THE OFFSPRING LATER IN LIFE
FANGXIAN LU1, EGLE BYTAUTIENE1, ESTHER TAMAYO1, PHYLLIS GAMBLE1, GARLAND D ANDERSON1, GARY DV HANKINS1, MONICA LONGO1, GEORGE SAADE1, 1University of Texas Medical Branch, Obstetrics & Gynecology/Maternal Fetal Medicine, Galveston, Texas
9:30
7
LOW BIRTH WEIGHT AMONG ADULTS WITH A FAMILY HISTORY OF DIABETES DECREASES THE RISK OF METABOLIC SYNDROME.
BETTINA PAEK1, KATHERINE EASTWOOD1, KRISTINA UTZSCHNEIDER2, JENNY TONG2, FERNANDO GERCHMAN2, DREW ROBILIO1, WILFRED FUJIMOTO2, STEVEN KAHN2, DARCY CARR1, 1University of Washington, Obstetrics and Gynecology, Seattle, Washington 2University of Washington, Medicine, Seattle, Washington
9:45
8
FETAL ORIGINS OF DISEASE: ESSENTIAL NUTRIENT SUPPLEMENTATION PREVENTS ADULT METABOLIC DISEASE IN A TRANSGENERATIONAL MODEL OF IUGR
KJERSTI AAGAARD-TILLERY1, WILLIAM HOLLAND2, ROBERT MCKNIGHT3, SHANNON JENKINS3, XING YU3, SCOTT SUMMERS2, WARE BRANCH4, ROBERT LANE3, 1University of Utah, Obstetrics and Gynecology, Salt Lake City, Utah 2University of Utah, Biochemistry and Molecular Biology, Salt Lake City, Utah 3University of Utah, Division of Neonatology, Salt Lake City, Utah 4University of Utah, Obstetrics and Gynecology, SLC, Utah
December 2006 XLIII
Thursday, February 8, 2007 1:15PM to 3:30PM
Oral Concurrent Session 1
Continental Ballroom 4
1:15
9
17 ALPHA HYDROXY-PROGESTERONE CAPROATE (17P) TREATMENT REDUCES CERVICAL SHORTENING INHIBITING CERVICAL INTERLEUKIN-1 SECRETION.
FABIO FACCHINETTI1, SIMONE PAGANELLI1, PAOLO VENTURINI1, GIULIA DANTE1, 1Universita` di Modena e Reggio Emilia, Modena, Italy
1:30
10
PROGESTERONE PROTECTS CHORION AND DECIDUA CELLS FROM CALCIUM INDUCED CELL DEATH IN PRIMARY CELL CULTURE
AMY MURTHA1, LIPING FENG1, BRYAN YONISH1, DAVID SCHOMBERG2, 1Duke University, Obstetrics and Gynecology, Durham, North Carolina 2Duke University, Cell Biology, Durham, North Carolina
1:45
11
THE EFFECT OF ANTEPARTUM PERIODONTAL THERAPY ON PRETERM BIRTH RATE ACCORDING TO CERVICAL LENGTH: A RANDOMIZED PILOT STUDY
SARAH SMITH1, ROBERT STRAUSS1, STEVEN OFFENBACHER2, KEVIN MOSS3, KIM BOGGESS1, SALLY TIMLIN4, JAMES BECK2, 1 University of North Carolina at Chapel Hill, Obstetrics/Gynecology, Chapel Hill, North Carolina 2University of North Carolina at Chapel Hill, Center for Oral and Systemic Diseases, Chapel Hill, North Carolina 3 University of North Carolina at Chapel Hill, Dental Ecology, Chapel Hill, North Carolina 4WakeMed, Obstetrics/Gynecology, Raleigh, North Carolina
2:00
12
NON-INVASIVE DIAGNOSIS OF INTRAAMNIOTIC INFECTION AND PRETERM BIRTH FROM PROTEOMIC ANALYSIS OF VAGINAL FLUID
JANE HITTI1, JODI LAPIDUS2, XINFANG LU3, LEONARDO PEREIRA4, DAVID ESCHENBACH1, MICHAEL GRAVETT5, SRINIVASA NAGALLA3, 1University of Washington, Obstetrics and Gynecology, Seattle, Washington 2Oregon Health & Science University, Public Health & Preventive Medicine, Portland, Oregon 3Oregon Health & Science University, Pediatrics, Portland, Oregon 4Oregon Health & Science University, Obstetrics and Gynecology, Portland, Oregon 5University of Washington, Obstetrics & Gynecology, Seattle, Washington
2:15
13
THE DIAGNOSTIC AND PROGNOSTIC VALUE OF MMP-8 PTD CHECK IN WOMEN WITH PRETERM PREMATURE RUPTURE OF MEMBRANES.
KUN WOO KIM1, HYUN SOO PARK1, SOON-SUP SHIM1, JONG KWAN JUN1, ROBERTO ROMERO2, BO HYUN YOON1, 1Seoul National University College of Medicine, Department of Obstetrics and Gynecology, Seoul, South Korea2Grosse pointe, Grosse pointe, Michigan
2:30
14
4-YEAR FOLLOW-UP OF CHILDREN EXPOSED TO 17ALPHA HYDROXYPROGESTERONE CAPROATE (17P) IN UTERO
ALLISON NORTHEN1, 1NICHD MFMU Network, Bethesda, Maryland
2:45
15
PROTEOMICS ANALYSIS OF AMNIOTIC FLUID. A NOVEL METHODOLOGY TO PROVIDE INSIGHT INTO THE MECHANISMS OF IDIOPATHIC PRETERM BIRTH
IRINA A. BUHIMSCHI1, VICTOR A. ROSENBERG1, SONYA S. ABDEL-RAZEQ1, STEPHEN F. THUNG1, CATALIN S. BUHIMSCHI1, 1Yale University, Ob./Gyn.&Reprod.Sci., New Haven, Connecticut
3:00
16
THE EFFECT OF ESTERASES ON 17HYDROXYPROGESTERONECAPROATE
RU YAN1, TATIANA NANOVSKAYA1, GARY HANKINS1, MAHMOUD AHMED1, 1University of Texas Medical Branch at Galveston, Obstetrics and Gynecology, Galveston, Texas
3:15
17
EX VIVO CYTOKINE PRODUCTION BY CELLS IN MID-TRIMESTER AMNIOTIC FLUID PREDICT SUBSEQUENT SPONTANEOUS PRETERM BIRTH (SPTB)
ANN MARIE BONGIOVANNI1, DEVRIM SEZEN1, CLAUDEL JEAN-PIERRE1, IARA LINHARES1, DANIEL SKUPSKI2, STEVEN WITKIN3, 1Weill Medical College of Cornell University, Obstetrics and Gynecology, New York, New York 2Cornell University, Obstetrics and Gynecology, Flushing, New York 3Cornell University, Obstetrics & Gynecology, New York, New York
XLIV December 2006
Thursday, February 8, 2007 1:15PM to 3:30PM
Oral Concurrent Session 2
Continental Ballroom 5
1:15
18
CHRONIC HYPOXIA INCREASES IL-6, TNF-, AND MATRIX METALLOPROTEINASES (MMP2 AND MMP9) EXPRESSION OF FETAL GUINEA PIG HEARTS
CHIEN OH1, YAFENG DONG2, LOREN THOMPSON1, 1University of Maryland at Baltimore, Obstetrics and Gynecology, Baltimore, Maryland 2 University of Kansas, Obstetrics and Gynecology, Kansas City, Kansas
1:30
19
PROTEOMIC ANALYSIS OF THE HUMAN AMNIOTIC FLUID (AF) TO PREDICT HISTOLOGICAL CHORIOAMNIONITIS (HCA) IN UTERO
IRINA A. BUHIMSCHI1, CHRISTIAN M. PETTKER1, LISSA K. MAGLOIRE1, STEPHEN F. THUNG1, GUOMAO ZHAO1, CAROLYN M. SALAFIA2, CATALIN S. BUHIMSCHI1, 1Yale University, Ob./ Gyn.& Reprod.Sci, New Haven, Connecticut 2Columbia University, Department of Epidemiology, Larchmont, New York
1:45
20
FETAL CORD BLOOD MONONUCLEAR CELLS COLLECTED AT TERM FROM HIV-1 INFECTED WOMEN HARBOR TRANSCRIPTIONALLY ACTIVE INTEGRATED HIV PROVIRAL DNA
JANE ELLIS1, GREG HAIR2, MICHAEL LINDSAY1, HARRIET WILLIAMS1, BRUCE SUNDSTROM2, 1Emory University, Department of Gynecology and Obstetrics, Atlanta, Georgia 2Emory University, Department of Pathology and Laboratory Medicine, Atlanta, Georgia
2:00
21
TLRS, THE LOWER GENITAL TRACT AND PREGNANCY
JUAN GONZALEZ1, JINGHUA CHAIR2, MICHAL ELOVITZ2, 1 Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 2 University of Pennsylvania, Philadelphia, Pennsylvania
2:15
22
THE CALCIUM BINDING PROTEIN S100, A MARKER FOR NEUROLOGIC INJURY IN THE PERINATAL PERIOD, IS INCREASED IN THE AMNIOTIC FLUID OF WOMEN WITH PRETERM LABOR AND INTACT MEMBRANES.
LARA FRIEL1, JIMMY ESPINOZA1, SAMUEL EDWIN2, JYH KAE NIEN2, RICARDO GOMEZ3, SONIA HASSAN1, TINNAKORN CHAIWORAPONGSA1, ROBERTO ROMERO2, 1Wayne State University School of Medicine, Department of Obstetrics and Gynecology, Detroit, Michigan 2Perinatology Research Branch, NICHD, NIH, DHHS, Detroit, Michigan 3CEDIP, Sotero del Rio Hospital, OB-GYN, Universidad Catolica de Chile, Puento Alto, Chile
2:30
23
PEPTIDE PROFILING OF MATERNAL SERUM TO DETECT SPONTANEOUS PRETERM BIRTH AND INTRA-AMNIOTIC INFECTION AMONG WOMEN IN PRETERM LABOR
LEONARDO PEREIRA1, JANE HITTI2, JODI LAPIDUS3, DAVID ESCHENBACH2, MICHAEL GRAVETT2, SRINIVASA NAGALLA4, 1 Oregon Health & Science University, Obstetrics and Gynecology, Portland, Oregon 2University of Washington, Obstetrics and Gynecology, Seattle, Washington 3Oregon Health & Science University, Public Health & Preventive Medicine, Portland, Oregon 4Oregon Health & Science University, Pediatrics, Portland, Oregon
2:45
24
PROTEIN EXPRESSION PROFILING OF EXTREMELY PRETERM PLACENTAS SUGGESTS DISTINCT PATHWAYS OF INTRAUTERINE INFLAMMATION
THOMAS MCELRATH1, RAINA FICHOROVA1, ELIZABETH ALLRED2, JONATHAN HECHT3, OLAF DAMMANN4, ALAN LEVITON2, 1Brigham and Women’s Hospital, Department of Obstetrics and Gynecology, Boston, Massachusetts 2Children’s Hospital of Boston, Neuroepidemiology Division, Boston, Massachusetts 3Beth Israel Deaconess Medical Center, Department of Pathology, Boston, Massachusetts 4Hannover Medical School, Neurology, Hannover, Germany
3:00
25
FETAL NUCLEATED RED BLOOD CELLS (NRBC) ARE REGULATED INDEPENDENTLY OF ERYTHROPOIETIN LEVELS IN A RAT MODEL OF INTRAUTERINE GROWTH RESTRICTION (IUGR)
VISWANATHAN RAVISHANKAR1, CATALIN S. BUHIMSCHI2, CARMEN BOOTH3, VINEET BHANDARI4, ERROL R. NORWITZ2, JOSHUA A. COPEL2, IRINA A. BUHIMSCHI2, 1State Univ. of NY, Ob./ Gyn.&Reprod. Med., Stony Brook, New York 2Yale University, Ob./ Gyn.&Reprod.Sci, New Haven, Connecticut 3Yale University, Comparative Medicine, New Haven, Connecticut 4Yale University, Pediatrics, New Haven, Connecticut
3:15
26
A ROLE FOR MICRORNAS – KEY REGULATORS OF GENE EXPRESSION – IN CHORIOAMNIONITIS AND PARTURITION
DANIEL MONTENEGRO1, ROBERTO ROMERO1, BETH L. PINELES1, ADI L TARCA2, YEON MEE KIM3, SORIN DRAGHICI2, JUAN PEDRO KUSANOVIC1, OFFER EREZ1, SHALI MAZAKITOVI4, SONIA HASSAN4, JIMMY ESPINOZA4, CHONG JAI KIM3, 1 Perinatology Research Branch, NICHD, NIH, DHHS, Detroit, Michigan 2 Wayne State University, Department of Computer Science, Detroit, Michigan 3Wayne State University School of Medicine, Department of Pathology, Detroit, Michigan 4Wayne State University School of Medicine, Department of Obstetrics and Gynecology, Detroit, Michigan
December 2006 XLV
Thursday, February 8, 2007 1:15PM to 3:30PM
Oral Concurrent Session 3
Continental Ballroom 6
1:15
27
REPEATED MEASURES SCREENING FOR TRISOMY 21 - RESULTS FROM A GENERAL POPULATION SCREENING TRIAL (THE FASTER TRIAL)
FERGAL D. MALONE1, DAVID WRIGHT2, HOWARD CUCKLE3, ROBERT H. BALL4, DAVID A. NYBERG5, CHRISTINE H. COMSTOCK6, GEORGE R. SAADE7, RICHARD L. BERKOWITZ8, SUSAN J. GROSS9, LORRAINE DUGOFF10, SABRINA D. CRAIGO11, ILAN E. TIMOR12, STEPHEN R. CARR13, HONOR M. WOLFE14, MARY E. D’ALTON15, 1Royal College of Surgeons in Ireland, Dublin, Ireland2University of Plymouth, Plymouth, United Kingdom3University of Leeds, Leeds, United Kingdom4University of California, San Francisco, California 5Swedish Medical Center, Seattle, Washington 6William Beaumont Hospital, Royal Oak, Michigan 7UTMB, Galveston, Texas 8 Mount Sinai Medical Center, New York, New York 9Albert Einstein College of Medicine, Bronx, New York 10University of Colorado Health Sciences Center, Denver, Colorado 11Tufts University, Boston, Massachusetts 12NYU Medical Center, New York, New York 13Brown University, Providence, Rhode Island 14University of North Carolina, Chapel Hill, North Carolina 15Columbia University, New York, New York
1:30
28
PREVENTION OF DEVELOPMENTAL DELAYS IN A DOWN SYNDROME MODEL
LAURA TOSO1, IRENE CAMERONI2, CECILIA SCHMIDT3, DANIEL ABEBE1, STEPHANIE BISSELL1, CATHERINE SPONG1, 1 National Institutes of Health (NIH), NICHD&NIAAA, Unit on Perinatal and Developmental Neurobiology, Bethesda, Maryland 2University of Milano-Bicocca, Obstetrics and Gynecology, Monza, Milan Italy3The Jackson Laboratory, Bar Harbor, Maine
1:45
29
NEUROPROTECTIVE PEPTIDES PREVENT THE ALCOHOL-INDUCED ALTERATION IN GABA-A3 WHICH PLAYS A ROLE IN CLEFT LIP AND PALATE IN FETAL ALCOHOL SYNDROME
LAURA TOSO1, DANIEL ABEBE1, ROBIN ROBERSON1, CATHERINE Y. SPONG1, 1National Institutes of Health (NIH), NICHD&NIAAA, Unit on Perinatal and Developmental Neurobiology, Bethesda, Maryland
2:00
30
TRENDS IN STATE/POPULATION-BASED DOWN SYNDROME (DS) SCREENING AND INVASIVE PRENATAL TESTING WITH THE INTRODUCTION OF FIRST TRIMESTER COMBINED DS SCREENING, SOUTH AUSTRALIA 1995-2004.
PETER MULLER1, CHRIS WILKINSON1, ROBERT COCCIOLONE2, RHONDA HUTCHINSON2, ERIC HAAN3, ANNABELLE CHAN4, 1 Women’s and Children’s Hospital, Perinatal Medicine, North Adelaide, South Australia Australia2Women’s and Children’s Hospital, Genetic Medicine, North Adelaide, South Australia Australia3Women’s and Children’s Hospital, Department of Genetic Medicine, Adelaide, South Australia Australia4Department of Health, Pregnancy Outcome Unit, Adelaide, South Australia Australia
2:15
31
FIRST-TRIMESTER RISK ASSESSMENT FOR TRISOMY 21 AND 18 IN TWIN PREGNANCY
STEPHEN CHASEN1, SRIRAM PERNI1, ROBIN B. KALISH1, FRANK A. CHERVENAK1, 1Weill Medical College of Cornell University, New York, New York
2:30
32
THE ROLE OF GENOME DAMAGE AND FOLATE NUTRIGENOMICS IN UTEROPLACENTAL INSUFFICIENCY (UPI)
DENISE FURNESS1, GUSTAAF DEKKER2, YEE KHONG3, BILL HAGUE4, MICHAEL FENECH5, 1CSIRO, Adelaide BC, South Australia Australia2Women’s and Children’s Hospital, Obstetrics and Gynaecology, North Adelaide, South Australia Australia3Women’s and Children’s Hospital, Adelaide, Obstetrics and Gynaecology, North Adelaide, South Australia Australia4Women’s and Children’s Hospital, Adelaide, North Adelaide, South Australia Australia5CSIRO, Human Nutrition, Adelaide, South Australia Australia
2:45
33
GENES IN GLUCOSE METABOLISM AND THEIR ASSOCIATION WITH SPINA BIFIDA
CHRISTINA DAVIDSON1, HOPE NORTHRUP2, TERRI KING2, JACK FLETCHER3, IRENE TOWNSEND3, GAYLE TYERMAN4, KIT SING AU2, 1University of Texas Health Science Center at Houston, Obstetrics, Gynecology and Reproductive Sciences, Houston, Texas 2 University of Texas Health Science Center at Houston, Pediatrics and Medical Genetics, Houston, Texas 3University of Houston-Texas Medical Center Annex, Psychology, Houston, Texas 4Shriners Hospitals for Children, Los Angeles, California
3:00
34
GENOMIC IMPRINTING DISORDERS AND BIRTH DEFECTS IN PREGNANCIES CONCEIVED WITH ASSISTED REPRODUCTIVE TECHNOLOGY (ART)
KATHERINE BIANCO1, MARY E NORTON1, VANESSA T ANGELES1, RENEE REIJO PERA1, 1University of California, San Francisco, Obstetrics, Gynecology and Reproductive Sciences, San Francisco, California
XLVI December 2006
3:15
35
EVIDENCE FOR A STEREOTYPIC DIFFERENCE IN POST-TRANSCRIPTIONAL REGULATION OF PLACENTAL GENE EXPRESSION IN PREECLAMPSIA AND SGA: AN EXPLANATION FOR THE TWO DIFFERENT PHENOTYPES?
BETH L. PINELES1, ROBERTO ROMERO1, DANIEL MONTENEGRO1, ADI L TARCA2, YU MI HAN1, YEON MEE KIM3, JUAN PEDRO KUSANOVIC1, POOJA MITTAL4, SONIA HASSAN4, JIMMY ESPINOZA4, CHONG JAI KIM3, 1Perinatology Research Branch, NICHD, NIH, DHHS, Detroit, Michigan 2Wayne State University, Department of Computer Science, Detroit, Michigan 3Wayne State University School of Medicine, Department of Pathology, Detroit, Michigan 4Wayne State University School of Medicine, Department of Obstetrics and Gynecology, Detroit, Michigan
December 2006 XLVII
Friday, February 9, 2007 Oral Plenary Session II (Fellows)
8:00AM to 10:00AM
Continental Ballroom 1-9
8:00
36
ADMINISTRATION OF CEFAZOLIN PRIOR TO SKIN INCISION IS SUPERIOR TO CEFAZOLIN AT CORD CLAMPING IN PREVENTING POSTCESAREAN INFECTIOUS MORBIDITY
SCOTT SULLIVAN1, TRIZ SMITH2, EUGENE CHANG1, THOMAS HULSEY3, J. VAN DORSTEN1, DAVID SOPER1, 1Medical University of South Carolina, Obstetrics and Gynecology, Charleston, South Carolina 2 Medical University of South Carolina, Obstetrics/Gynecology, Charleston, South Carolina 3Medical University of South Carolina, Pediatrics, Charleston, South Carolina
8:15
37
IMPACT OF INTERCONCEPTIONAL ANTIBIOTICS ON THE ‘‘ENDOMETRIAL FLORA’’
ALAN TITA1, SUE CLIVER1, ALICE GOEPFERT1, ROBERT GOLDENBERG1, MICHAEL CONNER2, WILLIAMS ANDREWS1, 1 University of Alabama at Birmingham, Obstetrics and Gynecology, Birmingham, Alabama 2University of Alabama at Birmingham, Pathology, Birmingham, Alabama
8:30
38
THE ROLE OF OXIDATIVE AND INFLAMMATORY STRESS IN THE DEVELOPMENTAL ORIGIN OF ADULT VASCULAR DYSFUNCTION
LABIB GHULMIYYAH1, SHANNON CLARK1, AMANDA MARETH1, PHYLLIS GAMBLE1, GARY DV HANKINS1, GARLAND D ANDERSON1, GEORGE SAADE1, MONICA LONGO1, 1University of Texas Medical Branch, Obstetrics & Gynecology/Maternal Fetal Medicine, Galveston, Texas
8:45
39
CHANGES IN CELLULAR CHOLESTEROL METABOLISM ARE ASSOCIATED WITH FETAL PROGRAMMING OF ATHEROSCLEROSIS.
NIMA GOHARKHAY1, KARINA VILLARREAL1, SERGIO RODRIGUEZ1, AMANDA MARETH1, KENDRA STISSER2, ESTHER TAMAYO1, PHYLLIS GAMBLE1, MICHEL MAKHLOUF1, GARLAND D ANDERSON1, MONICA LONGO1, GEORGE SAADE1, 1 University of Texas Medical Branch, Obstetrics & Gynecology/Maternal Fetal Medicine, Galveston, Texas 2University of Texas Medical Branch, Obstetrics & Gynecology/Gynecologic Oncology, Galveston, Texas
9:00
40
SYNCYTIOTROPHOBLASTS OF PREECLAMPTIC PLACENTAS OVEREXPRESS CORTICOTROPINRELEASING HORMONE MRNA
LYDIA LEE1, FERNANDA HEITOR2, HARVEY KLIMAN3, THOMAS MCELRATH1, JOSEPH MAJZOUB2, 1Harvard University, Department of Obstetrics and Gynecology, Boston, Massachusetts 2 Children’s Hospital of Boston, Endocrinology, Boston, Massachusetts 3 Yale University, Obstetrics & Gynecology, New Haven, Connecticut
9:15
41
HYPOXIA ENHANCES DEPOSITION OF THE C5B-9 MEMBRANE ATTACK COMPLEX OF COMPLEMENT ON HUMAN TROPHOBLASTS
ROXANE RAMPERSAD1, AARON BARTON1, YOEL SADOVSKY2, D. NELSON1, 1Washington University in St. Louis, Obstetrics & Gynecology, St. Louis, Missouri 2Washington University in St. Louis, Cell Biology & Physiology, St. Louis, Missouri
9:30
42
PLACENTAL GENE TRANSFER OF IGF-1 CORRECTS FETAL GROWTH RESTRICTION
URSULA HARKNESS1, JIGNESH PARVADIA1, MARIA RIPBERGER1, SACHIN VAIKUNTH1, EVA UZVOLGYI1, DATIS ALAEE1, A. MARWAN1, BARBARA KALINOWSKA1, ARTURO MALDONADO1, SUZI DEMIRBAG1, TIMOTHY CROMBLEHOLME1, 1Cincinnati Children’s Hospital Medical Center, Center for Molecular Fetal Therapy, University of Cincinnati, Cincinnati, Ohio
9:45
43
GENOMIC DNA METHYLATION PATTERNS ARE FUNCTIONALLY ALTERED AMONG OFFSPRING IN A NON-HUMAN PRIMATE MODEL OF MATERNAL OBESITY
KJERSTI AAGAARD-TILLERY1, ROBERT MCKNIGHT2, ANDRZEJ POPLAWSKI3, JAN DUMANSKI3, ROBERT SILVER1, KEVIN GROVE4, ROBERT LANE2, 1University of Utah, Obstetrics and Gynecology, Salt Lake City, Utah 2University of Utah, Division of Neonatology, Salt Lake City, Utah 3University of Alabama at Birmingham, Genetics, Birmingham, Alabama 4Oregon Health & Science University, ONPRC Research Neuro, Portland, Oregon
XLVIII December 2006
Friday, February 9, 2007 1:15PM to 3:30PM
Oral Concurrent Session 4
Continental Ballroom 4
1:15
44
NIH SPONSORED PROSPECTIVE RANDOMIZED CLINICAL TRIAL OF AMNIOREDUCTION VS SELECTIVE FETOSCOPIC LASER PHOTOCOAGULATION FOR TWIN-TWIN TRANSFUSION SYNDROME
TIMOTHY CROMBLEHOLME1, DAVID SHERA2, FLINT PORTER3, HANMIN LEE4, CHYU JACQUELYN5, RICHARD K. SILVER6, ALFRED ABUHAMAD7, MARK JOHNSON8, GEORGE R. SAADE9, MARY D’ALTON10, LARRY SHIELDS11, KAUFFMAN DAVID12, JOANNE STONE13, JEFFREY LIVINGSTON14, WILLIAM POLZIN15, ROBERT LORENZ16, BRUCE YOUNG17, DAVID A. MILLER18, ANTHONY ODIBO19, JACK RYCHIK20, LYNN SIMPSON21, VICKIE FELDSTEIN22, BEVERLY COLEMAN23, EDUARDO RUCHELLI24, LARISSA BILANIUK25, ERIN SIMON25, BETTY VOHR26, ISTVAN SERI27, 1Cincinnati Children’s Hospital Medical Center, Fetal Care Center, Cincinnati, Ohio 2Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania 3University of Utah, Perinatology, Salt Lake City, Utah 4 University of California, San Francisco, Surgery, Pediatrics, & OB/GYN, San Francisco, California 5University of Colorado Health Sciences Center, Denver, Colorado 6Evanston Hospital, Obstetrics and Gynecology, Evanston, Illinois 7Eastern Virginia Medical School, Obstetrics And Gynecology, Norfolk, Virginia 8Children’s Hospital of Philadelphia, Center for Fetal Diagnosis & Treatment, Philadelphia, Pennsylvania 9University of Texas Medical Branch at Galveston, Obstetrics & Gynecology, Galveston, Texas 10Columbia University, Obstetrics and Gynecology, New York, New York 11University of Washington, Obstetrics and Gynecology, Seattle, Washington 12Magee-Women’s Hospital, Pittsburgh, Pennsylvania 13 Mount Sinai School of Medicine, Obstetrics or Gynecology, New York, New York 14University of Cincinnati, Fetal Care Center, Obstetrics and Gynecology, Cincinnati, Ohio 15Good Samaritan Hospital, Cincinnati, Ohio 16Willam Beaumont Hospital, Royal Oak, Michigan 17New York University, Obstetrics and Gynecology, New York City, New York 18Queen of Angels Hollywood Presbyterian Medical Center, Obstetrics and Gynecology/MFM, Los Angeles, California 19University of Pennsylvania Medical Center, Obstetrics & Gynecology, Philadelphia, Pennsylvania 20 Children’s Hospital of Philadelphia, Fetal Heart Program, Philadelphia, Pennsylvania 21Columbia University, Faculty of Medicine, Briarcliff Manor, New York 22University of California, San Francisco, Radiology, San Francisco, California 23Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 24Children’s Hospital of Philadelphia, Pathology Department, Philadelphia, Pennsylvania 25Children’s Hospital of Philadelphia, Department of Radiology, Philadelphia, Pennsylvania 26 Brown University, Pediatrics, Providence, Rhode Island 27University of Southern California, Los Angeles, California
1:30
45
MATERNAL HYPEROXYGENATION TEST IN FETUSES WITH PRENATALLY TREATED SEVERE DIAPHRAGMATIC HERNIA: LONGITUDINAL OBSERVATION STUDY.
ELISA DONE’1, JACQUES JANI1, DOMINIQUE VAN SCHOUBROECK1, ANNE DEBEER2, JAN DEPREST1, 1University Hospital Leuven Belgium, Obstetrics and Gynecology, Leuven, Belgium2University Hospital Leuven Belgium, Neonatology, Leuven, Belgium
1:45
46
RISK OF BIRTH DEFECTS IN PREGNANCIES ASSOCIATED WITH ASSISTED REPRODUCTIVE TECHNOLOGY
DARINE EL-CHAAR1, QIUYING YANG2, JIM BOTTOMELY3, SHI WU WEN2, MARK WALKER2, 1University of Ottawa, Obstetrics and Gynecology, Ottawa, Ontario Canada2OMNI Research Group, Ottawa Health Research Institute, Ottawa, Ontario Canada3Perinatal Partnership of Eastern Ontario, Ottawa, Ontario Canada
2:00
47
LOWER EXTREMITY NEUROMOTOR FUNCTION FOLLOWING IN UTERO MYELOMENINGOCELE REPAIR
ENRICO DANZER1, SCOTT ADZICK1, MARSHA GERDES1, MICHAEL BEBBINGTON1, LESLIE SUTTON1, JEANNE MELCHIONNI1, MARK JOHNSON1, 1Children’s Hospital of Philadelphia, Center for Fetal Diagnosis and Treatment, Philadelphia, Pennsylvania
2:15
48
LONG TERM PULMONARY GENE THERAPY WITH A LENTIVIRAL VECTOR IN A FETAL RAT MODEL.
JAAN TOELEN1, GIJSBERS RIK1, LOURENc¸O SBRAGIA1, DEROOSE CHRISTOPHE1, ZEGER DEBYSER1, JAN DEPREST2, 1 Catholic University of Leuven, Molecular Virology and Gene Therapy, Leuven, Belgium2University Hospital Leuven Belgium, Leuven, Brabant Belgium
December 2006 XLIX
2:30
49
VALIDATION OF THE NEONATAL ENCEPHALOPATHY COMMITTEE OPINION IN ACUTELY ASPHYXIATED NEONATES WITH PERMANENT BRAIN INJURY
JEFFREY PHELAN1, LISA MARIE KORST2, GILBERT I. MARTIN3, 1 Citrus Valley Medical Center, OB/GYN, West Covina, California 2USC Keck School of Medicine, OB/Gyn, Women’s & Children’s Hospital, Los Angeles, California 3Citrus Valley Medical Center, Neonatology, West Covina, California
2:45
50
PROGNOSTIC VALUE OF AMNIOTIC FLUID BRAIN NATRIURETIC PEPTIDE (BNP) IN FETAL AORTIC STENOSIS
WALTER LUBBERS1, DAWN BURMAN1, SCOTT BAKER1, PIROOZ EGHTESADY1, 1Children’s Hospital Medical Center of Cincinnati, Cardiothoracic Surgery, Cincinnati, Ohio
3:00
51
A RANDOMIZED PROSPECTIVE TREATMENT TRIAL FOR PATIENTS WITH ‘‘STANDARD RISK’’ ALLOIMMUNE THROMBOCYTOPENIA (AIT)
RICHARD BERKOWITZ1, JAMES B. BUSSEL2, CRYSTAL HUNG3, MEGAN WISSERT3, 1Columbia Presbyterian Medical Center, New York, New York 2New York Weill Cornell Medical Center, Pediatric Hematology, New York, New York 3Cornell University, Department of Pediatric Hematology, New York, New York
3:15
52
A MURINE MODEL OF FETAL PROGRAMMING OF ATHEROSCLEROSIS: MORPHOLOGIC AND HISTOLOGIC CHARACTERIZATION
NIMA GOHARKHAY1, FANGXIAN LU1, ELENA SBRANA2, PHYLLIS GAMBLE1, ANCIZAR BETANCOURT1, ESTHER TAMAYO1, KARINA VILLARREAL1, GARY DV HANKINS1, MONICA LONGO1, GEORGE R SAADE1, 1University of Texas Medical Branch, Obstetrics & Gynecology/Maternal Fetal Medicine, Galveston, Texas 2University of Texas Medical Branch, Pathology, Galveston, Texas
L December 2006
Friday, February 9, 2007 1:15PM to 3:30PM
Oral Concurrent Session 5
Continental Ballroom 5
1:15
53
THE RELATIONSHIP BETWEEN CHANGES IN PREPREGNANCY BMI BETWEEN PREGNANCIES AND INDICATIONS FOR PRIMARY CESAREAN DELIVERY.
DARIOS GETAHUN1, LILLIAN KAMINSKY1, DENISE ELSASSER1, RUSSELL KIRBY2, CANDE ANANTH1, ANTHONY VINTZILEOS1, 1 University of Medicine and Dentistry of New Jersey, Obstetrics, Gynecology and Reproductive Sciences, New Brunswick, New Jersey 2 University of Alabama at Birmingham, School of Public Health, Birmingham, Alabama
1:30
54
MCDONALD VS. SHIRODKAR: OUTCOMES IN THE EXPECTANT MANAGEMENT COMPARED TO PHYSICAL EXAM-INDICATED CERCLAGE (EMPEC) INTERNATIONAL COHORT STUDY
PATRICIA ROBERTSON1, SURASITH CHAITHONGWONGWATTHANA2, SEAN DALY3, LEONARDO PEREIRA1, JUHA RASANEN4, AMANDA COTTER5, WITOON PRASERTCHAROENSUK6, RICARDO GOMEZ7, SUNEETA MITTAL8, VINCENZO BERGHELLA9, S. LIMPONGSANURAK10, JORGE E. TOLOSA1, 1Oregon Health & Science University, Global Network for Perinatal and Reproductive Health, Obstetrics and Gynecology, Portland, Oregon 2Chulalongkorn University, Department of Obstetrics and Gynecology, Bangkok, Thailand3Coombe Women´s Hospital, Dublin, Ireland4University of Oulu, Obstetrics and Gynecology, Oulu, Finland5University of Miami, Obstetrics and Gynecology, Miami, Florida 6Khon Kaen University, Khon Kaen, Thailand7CEDIP, Sotero del Rio Hospital, Puente Alto, Chile8All India Institute of Medical Sciences, New Delhi, India9Thomas Jefferson University, Obstetrics and Gynecology, Philadelphia, Pennsylvania 10Chulalongkorn University, Obstetrics & Gynecology, Bangkok, Thailand
1:45
55
MATERNAL SMOKING AND DECREASED 5METHYLTETRAHYDROFOLATE IN UMBILICAL CORD PLASMA
ROBERT SOKOL1, ROBERT PAWLOSKY2, JOHN HANNIGAN3, KEN STARK4, NORMAN SALEM5, 1Wayne State University, Obstetrics/ Gynecology, Detroit, Michigan 2National Institute on Alcohol Abuse and Alcoholism, Division of Intramural Clinical and Biological Research, Bethesda, Maryland 3Wayne State University, Obstetrics and Gynecology, Detroit, Michigan 4University of Waterloo, Kinesiology, Waterloo, Ontario Canada5National Institutes of Health (NIH), hn556, Rockville, Maryland
2:00
56
INCREASED RECURRENCE OF PRETERM DELIVERY WITH EARLY CESSATION OF 17 ALPHA-HYDROXYPROGESTERONE CAPROATE
ANDREI REBARBER1, LAUREN FERRARA1, MARY ELLEN HANLEY2, NIKI ISTWAN3, DEBBIE RHEA3, GARY STANZIANO3, DANIEL SALTZMAN1, 1Mount Sinai School of Medicine, Maternal Fetal Medicine, New York, New York 2Valley Hospital, Maternal Fetal Medicine, Paramus, New Jersey 3Matria Healthcare, Clinical Research, Marietta, Georgia
2:15
57
THE ROLE OF PROTEASE ACTIVATED RECEPTOR 1 (PAR1) THROMBIN RECEPTOR POLYMORPHISMS IN RECURRENT PREGNANCY LOSS (RPL) - NOT ONLY COAGULATION
ARON TEVET1, GEONA ALTARESCU2, EHUD MARGALIOT3, ARNON SAMUELOFF4, RACHEL BAR-SHAVIT5, SORINA GRANOVSKY-GRISARU6, 1Shaare Zedek Medical Center, Jerusalem, Obstetrics and Gynecology, Jerusalem, Israel2Shaare Zedek Medical Center, Genetics, Jerusalem, Israel3Shaare Zedek Medical Center, Obstetrics Gynecology, Jerusalem, Israel4Shaare Zedek Medical Center, Obstetrics and Gynecology, affiliated with Ben-Gurion University of the Negev, BeerSheva, Jerusalem, Israel5Tumor Biology, Hadassah Hospital and the Hebrew University, Jerusalem, Oncology&Tumor Biology, Jerusalem, Israel6Shaare Zedek Medical Center, Obsterics Gynecology, Jerusalem, Israel
2:30
58
BIRTH ORDER OF TWINS AND THE RISK OF DELIVERY RELATED PERINATAL DEATH IN ENGLAND, NORTHERN IRELAND AND WALES, 1994-2003.
GORDON SMITH1, KATE FLEMING2, IAN WHITE3, 1University of Cambridge, Obstetrics & Gynaecology, Cambridge, United Kingdom2Confidential Enquiry into Maternal and Child Health, London, United Kingdom3MRC Biostatistics Unit, Cambridge, UK, Cambridge, United Kingdom
2:45
59
WHEN SHOULD WOMEN WITH PLACENTA PREVIA BE DELIVERED?: A DECISION ANALYSIS
MARYA ZLATNIK1, SARAH LITTLE1, PUJA KOHLI1, NAOMI STOTLAND1, ANJALI KAIMAL1, AARON CAUGHEY1, 1University of California, San Francisco, Obstetrics, Gynecology and Reproductive Sciences, San Francisco, California
December 2006 LI
3:00
60
A PROSPECTIVE, RANDOMIZED TRIAL OF TRANSCERVICAL FOLEY CATHETER WITH OR WITHOUT OXYTOCIN FOR PREINDUCTION CERVICAL RIPENING
CHRISTIAN M. PETTKER1, SEAN B. POCOCK2, DOROTHY P. SMOK2, PATRICIA C. DEVINE2, 1Yale University, Obstetrics, Gynecology, and Reproductive Sciences, New Haven, Connecticut 2 Columbia University Medical Center, Division of Maternal-Fetal Medicine, Department of Obstetrics & Gynecology, New York, New York
3:15
61
DESCRIPTIVE STUDY OF POSTPARTUM HEADACHE
CAROLINE STELLA1, CHRISTIANO JODICKE1, HELEN HOW1, URSULA HARKNESS1, BAHA SIBAI1, 1University of Cincinnati, Obstetrics & Gynecology, Cincinnati, Ohio
LII December 2006
Friday, February 9, 2007 1:15PM to 3:30PM
Oral Concurrent Session 6
Continental Ballroom 6
1:15
62
NEONATAL OUTCOME IN MONOCHORIONIC TWINS WITH TWIN-TO-TWIN TRANSFUSION SYNDROME FOLLOWING INTRAUTERINE TREATMENT WITH AMNIOREDUCTION OR FETOSCOPIC LASER SURGERY: COMPARISON WITH DICHORIONIC TWINS MATCHED FOR GESTATIONAL AGE
LENCLEN RICHARD1, CIARLO GIUSEPPINA1, PAUPE ALAIN1, ORTQVIST LISA2, VILLE YVES2, 1Centre Hospitalier Poissy-St Germain, Neonatology, Poissy, France2Centre Hospitalier Poissy-St Germain, Fetal Medicine, Obstetrics, Poissy, France
1:30
63
THE EFFECT OF THE POSTNATAL ENVIRONMENT ON ALTERED FETAL PROGRAMMING OF ADULT VASCULAR FUNCTION
SHANNON CLARK1, MICHEL MAKHLOUF1, GARY DV HANKINS1, GARLAND D ANDERSON1, GEORGE SAADE1, MONICA LONGO1, 1University of Texas Medical Branch, Obstetrics & Gynecology/Maternal Fetal Medicine, Galveston, Texas
1:45
64
PROSPECTIVE CARDIAC MONITORING IN FETUSES AT RISK OF CONGENITAL HEART BLOCK: THE PR INTERVAL & DEXAMETHASONE EVALUATION (PRIDE) STUDY
JOSHUA COPEL1, DEBBIE FRIEDMAN2, MIMI KIM3, CLAUDINE DAVIS4, JILL BUYON4, 1Yale University, Obstetrics & Gynecology, New Haven, Connecticut 2Saint Barnabas Medical Center, Pediatric Cardiology, Livingston, New Jersey 3Albert Einstein College of Medicine, New York, New York 4New York University, Medicine / Rheumatology, New York, New York
2:00
65
DUCTUS VENOSUS VELOCIMETRY IN FETAL HYPOXIA AND ACIDEMIA
KAARIN MAKIKALLIO1, GANESH ACHARYA2, TIINA ERKINARO3, MERVI HAAPSAMO1, TOMI KAVASMAA3, JAMES HUHTA2, JUHA RASANEN1, 1University of Oulu, Obstetrics and Gynecology, Oulu, Finland2University of South Florida, Pediatrics, St. Petersburg, Florida 3University of Oulu, Anesthesiology, Oulu, Finland
2:15
66
TERBUTALINE VERSUS NITROGLYCERIN FOR ACUTE INTRAPARTUM FETAL RESUSCITATION
KRISTIN PULLEN1, LARISA TAYLOR1, SARAH WALLER1, ELIZABETH LANGEN1, MAURICE DRUZIN1, EDWARD RILEY2, AARON CAUGHEY3, YASSER EL-SAYED1, 1Stanford University, Obstetrics and Gynecology, Stanford, California 2Stanford University, Anesthesia, Stanford, California 3University of California, San Francisco, Obstetrics, Gynecology, and Reproductive Sciences, San Francisco, California
2:30
67
THE EFFECT OF ORAL EVENING PRIMROSE OIL ON BISHOP SCORE AND CERVICAL LENGTH AMONG TERM GRAVIDAS
KAREN ALESSANDRA TY-TORREDES1, 1Our Lady of Lourdes Hospital, Obstetrics and Gynecology, Manila, Philippines
2:45
68
A RANDOMIZED CONTROLLED TRIAL OF TRANSCERVICAL FOLEY CATHETER WITH AND WITHOUT EXTRA-AMNIOTIC SALINE INFUSION (EASI) FOR LABOR INDUCTION
MONIQUE LIN1, MATTHEW TREASTER2, KIMBERLY REID3, FRANCIS NUTHALAPATY4, PATRICK RAMSEY5, GEORGE LU6, 1 University of Alabama at Birmingham, Obstetrics and Gynecology, Birmingham, Alabama 2University of Missouri-Kansas City, Department of Obstetrics and Gynecology, Kansas City, Missouri 3St. Lukes Hospital of Kansas City, Kansas City, Missouri 4University of Alabama at Birmingham, Obstetrics & Gynecology, Greenville, South Carolina 5 University of Alabama at Birmingham, Obstetrics/Gynecology, Birmingham, Alabama 6Obstetrix Medical Group of Kansas & Missouri, Kansas City, Missouri
3:00
69
GENE EXPRESSION SIGNATURE PATHWAYS IN THE HUMAN UTERINE CERVIX BEFORE AND AFTER SPONTANEOUS TERM PARTURITION
SONIA HASSAN1, ROBERTO ROMERO2, ADI L TARCA3, SORIN DRAGHICI3, NAHLA KHALEK1, NATALIA CAMACHO1, POOJA MITTAL1, BO HYUN YOON4, JIMMY ESPINOZA1, YORAM SOROKIN1, JOHN MALONE, JR.1, 1Wayne State University School of Medicine, Department of Obstetrics and Gynecology, Detroit, Michigan 2 Perinatology Research Branch, NICHD, NIH, DHHS, Detroit, Michigan 3 Wayne State University, Department of Computer Science, Detroit, Michigan 4Seoul National University College of Medicine, Department of Obstetrics and Gynecology, Seoul, South Korea
3:15
70
PHARMACOGENOMICS OF MATERNAL TOBACCO USE: METABOLIC GENE POLYMORPHISMS MODIFY RISK OF ADVERSE PREGNANCY OUTCOMES
KJERSTI AAGAARD-TILLERY1, 1for the NICHD MFMU Network, Bethesda, Maryland
December 2006 LIII
Saturday, February 10, 2007 8:00AM to 10:00AM
Oral Concurrent Session 7
Continental Ballroom 4
8:00
71
PARADOXIC INCREASE IN GLOMERULAR NUMBER OF OFFSPRING EXPOSED TO MATERNAL HYPERNATREMIA
ROY Z. MANSANO1, MINA DESAI1, AMBICA GARG1, GYU YEON CHOI1, MICHAEL ROSS1, 1Harbor-UCLA Med. Ctr. (LA BioMed), Dept. of Ob/Gyn, Torrance, California
8:15
72
PGE2 INDUCED CERVICAL RIPENING MODULATES PROTEOGLYCAN EXPRESSION
TANYA DAILEY1, HUILING JI1, VIT LONG1, DJURO JOSIC2, EDWARD K CHIEN1, 1Brown University, Women & Infants Hospital of Rhode Island, Providence, Rhode Island 2Brown University, Pathology, Providence, Rhode Island
8:30
73
PROGRAMMED HEPATIC LIPID DYSREGULATION IS INDEPENDENT OF OBESITY
GYU YEON CHOI1, AMBICA GARG1, ROY Z. MANSANO1, MICHAEL ROSS1, MINA DESAI1, 1Harbor-UCLA Med. Ctr. (LA BioMed), Dept. of Ob/Gyn, Torrance, California
8:45
74
UNIQUE REGULATORY LYMPHOCYTE IN FIRST TRIMESTER HUMAN DECIDUA
HAGAI AMSALEM1, ANAT GAIGER2, SAHAR MIZEACHI3, SIMCHA YAGEL1, JACOB RACHMILEWITZ2, 1Departments of Obstetrics & Gynecology, Hebrew University Hadassah Medical Center, Jerusalem, Israel2Hadassah University Hospital Jerusalem, Goldyne Savad Institute of Gene Therayp, jerusalem, Israel3Hadassah University Hospital Jerusalem, The Lautenberg Center for General and Tumor Immunology, Jerusalem, Israel
9:00
75
DEVELOPMENTAL ENHANCEMENT IN THE NEONATAL PERIOD IN HEALTHY MICE
LAURA TOSO1, IRENE CAMERONI2, DANIEL ABEBE1, CATHERINE SPONG1, 1Unit on Perinatal and Developmental Neurobiology, NICHD&NIAAA, National Institute of Health (NIH), Bethesda, Maryland 2University of Milano-Bicocca, Obstetrics and Gynecology, Monza, Milan Italy
9:15
76
FETAL PROGRAMMING OF BLOOD PRESSURE IN A TRANSGENIC MOUSE MODEL OF ALTERED INTRAUTERINE ENVIRONMENT
MONICA LONGO1, FANGXIAN LU1, ESTHER TAMAYO1, PHYLLIS GAMBLE1, GARLAND D ANDERSON1, GARY DV HANKINS1, GEORGE SAADE1, 1University of Texas Medical Branch, Obstetrics & Gynecology/Maternal Fetal Medicine, Galveston, Texas
9:30
77
MULTI-DRUG RESISTANCE RECEPTORS REGULATE TRANSMISSION OF THERAPEUTIC AGENTS ACROSS THE PLACENTA
SAMUEL PARRY1, JIAN ZHANG1, 1University of Pennsylvania, Obstetrics and Gynecology, Philadelphia, Pennsylvania
9:45
78
DURATION OF LACTATION AND INCIDENCE OF MYOCARDIAL INFARCTION
ALISON STUEBE1, KARIN MICHELS1, WALTER WILLETT2, JOANN MANSON3, JANET RICH-EDWARDS3, 1Brigham and Women’s Hospital, Harvard Medical School, Department of Obstetrics and Gynecology, Boston, Massachusetts 2Harvard School of Public Health, Boston, Massachusetts 3Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
LIV December 2006
Saturday, February 10, 2007 8:00AM to 10:00AM
Oral Concurrent Session 8
Continental Ballroom 6
8:00
79
TREATMENT OF GESTATIONAL DIABETES MELLITUS: ORAL HYPOGLYCEMIC AGENTS COMPARED TO SUBCUTANEOUS INSULIN THERAPY
YVONNE CHENG1, JUDITH CHUNG2, INGRID BLOCKKURBISCH1, MARIBETH INTURRISI3, AARON CAUGHEY1, 1 University of California, San Francisco, Department of Obstetrics, Gynecology and Reproductive Sciences, San Francisco, California 2 University of California, Irvine, Obstetrics and Gynecology, Orange, California 3University of California, San Francisco, School of Nursing, San Francisco, California
8:15
80
IN UTERO PROGRAMMING OF VASCULAR FUNCTION IN THE GESTATIONAL DIABETIC (LEPR/D) DB MOUSE.
MICHEL MAKHLOUF1, ESTHER TAMAYO1, PHYLLIS GAMBLE1, GARLAND D ANDERSON1, GEORGE SAADE1, MONICA LONGO1, 1 University of Texas Medical Branch, Obstetrics & Gynecology/Maternal Fetal Medicine, Galveston, Texas
8:30
81
PODOCYTURIA IS A SENSITIVE AND SPECIFIC MARKER FOR PREECLAMPSIA
DAVID ROSENTHAL1, BRIAN BROST2, WILLIAM WATSON2, LARISA GAVRILOVA3, STEPHEN TURNER4, JOSEPH GRANDE5, VESNA GAROVIC6, 1Mayo Foundation for Medical Education and Research, Nephrology and Hypertension, Rochester, Minnesota 2Mayo Clinic College of Medicine, Maternal Fetal Medicine Division, Rochester, Minnesota 3Mayo Clinic College of Medicine, Rochester, Minnesota 4Mayo Foundation for Medical Education and Research, Internal Medicine, Rochester, Minnesota 5Mayo Foundation for Medical Education and Research, Pathology, Rochester, Minnesota 6Mayo Clinic College of Medicine, Nephrology and Hypertension, Rochester, Minnesota
8:45
82
IDENTIFICATION OF SFLT1 POLYA SIGNAL SEQUENCES AND MAPPING INTRONIC CISELEMENTS THAT REGULATE SFLT1 IN HUMAN PLACENTA.
CHRISTIE THOMAS1, KANG ZIU LIU2, 1University of Iowa and Department of Veterans Affairs, Internal Medicine & Molecular Biology, Iowa City, Iowa 2University of Iowa, Internal Medicine, Iowa City, Iowa
9:00
83
IN VITRO VASCULAR REACTIVITY IN A MOUSE MODEL OF PREECLAMPSIA INDUCED BY OVEREXPRESSION OF SFLT-1
FANGXIAN LU1, MONICA LONGO1, PHYLLIS GAMBLE1, ESTHER TAMAYO1, GARLAND D ANDERSON1, GARY DV HANKINS1, GEORGE SAADE1, 1University of Texas Medical Branch, Obstetrics & Gynecology/Maternal Fetal Medicine, Galveston, Texas
9:15
84
HUMAN HTRA1 RETARDS JEG-3 CHORIOCARCINOMA CYTOTROPHOBLAST INVASION IN VITRO
FUNMINIYI AJAYI1, VIJI SHRIDHAR2, BRIAN BROST1, WILLIAM WATSON1, JEREMY CHIEN2, 1Mayo Clinic College of Medicine, Maternal Fetal Medicine Division, Rochester, Minnesota 2Mayo Clinic College of Medicine, Pathology and Laboratory Medicine, Rochester, Minnesota
9:30
85
EFFECT OF SUBSEQUENT PREGNANCY ON VASCULAR FUNCTION IN ENDOTHELIAL NITRIC OXIDE SYNTHASE (NOS3) KNOCKOUT MICE
LABIB GHULMIYYAH1, SHANNON CLARK1, ESTHER TAMAYO1, PHYLLIS GAMBLE1, GARY HANKINS DV1, GARLAND D ANDERSON1, GEORGE SAADE1, MONICA LONGO1, 1University of Texas Medical Branch, Obstetrics & Gynecology/Maternal Fetal Medicine, Galveston, Texas
9:45
86
CIRCULATING ANGIOGENIC FACTORS IN SMOKERS AND NON-SMOKERS DURING NORMOTENSIVE PREGNANCY
RICHARD LEVINE1, CONG QIAN2, KAI YU1, BAHA SIBAI3, ANANTH KARUMANCHI4, 1Department of Health and Human Services, National Institute of Child Health and Human Development, Division of Epidemiology, Statistics, and Prevention Research, Bethesda, Maryland 2Allied Technology Group, Rockville, Maryland 3University of Cincinnati, Obstetrics and Gynecology, Cincinnati, Ohio 4Center for Vascular Biology, Division of Nephrology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts
December 2006 LV